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ABSTRACT
The School of Graduate Studies
The University of Alabama in Huntsville
Degree: Master of Science

College/Dept.: Science/Biological Sciences

Name of Candidate: Darren Ferree
Title: Identification of the Molecular Target of the Doc Toxin of the P1 Bacteriophage
Plasmid Addiction System.
Doc toxin from the bacteriophage P1 plasmid addiction operon kills daughter cells that are
cured of plasmid. At the beginning of this project it was known that Doc is a kinase that transfers
the phosphoryl group from the gamma position of ATP to some unidentified target protein of
approximately 45 kDa molecular weight. To better characterize this target, assays were
conducted to determine optimal conditions for Doc-dependent phosphorylation of target, and
these conditions were then used to generate samples for analysis by two-dimensional
polyacrylamide gel electrophoresis, liquid chromatography-coupled tandem mass spectrometry,
and immunoprecipitation. The results of these experiments indicate that some particular species
of bacterial Elongation Factor Tu (EF-Tu) is the target of Doc but that not all species of EF-Tu
are readily phosphorylated by Doc.
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CHAPTER 1

INTRODUCTION

1.1 Defining Toxins
There exists in both academic and common usage a range of more or less discordant
definitions of the term ‘toxin’. This is perhaps to be expected given the word’s rather
recent coinage. The Oxford English Dictionary (OED) reports that ‘toxin’ entered the
English language by way of E.R. Lankester’s essay ‘Biology and the State’ in 1890
(Oxford University Press, 2014b). In it, he writes:
“...there are facts with regard to some kinds of infective virus and their
appropriate ‘vaccins’ which lead to the supposition that immunity is conferred,
not by the action of weak doses of the ‘toxin’ or actual poison of the virus, but by
the action of a distinct chemical substance which exists side by side with the
‘toxin.’” (Lankester 1890, p. 113)
After Lankester, it was used twice more in the literature—both times in reference to a
poisonous substance of biological origin—before G.A. Reid in 1905 further focused the
definition with the following claim (Reid 1906, p. 21):
“Toxins, extremely complex chemical compounds, are defensive weapons which
protect the organisms producing them from their enemies, the phagocytes of the
blood and tissues.”

1

Thus the word toxin came to maturity in the scientific literature in just sixteen years,
though its usage remains distressingly fluid. The OED itself defines a toxin as a “specific
poison, usually of an albuminous nature, esp. one produced by a microbe, which causes a
particular disease when present in the system of a human or animal body” (Oxford
University Press, 2014b). Here the use of ‘albuminous’ is unfortunate as the word can
refer to a substance containing many different chemical components (Oxford University
Press, 2014a), thus failing to recognize that any given toxin has a singular molecular
identity whereas poisons or venoms may be serous or albuminous substances containing a
number of different toxins. For example, bee venom contains a number of enzymes,
allergenic proteins, and small peptides (Conn, 2008), each of which may be purified and
demonstrated to be a discrete toxin independent of any other component.
Here G.A. Reid’s definition of toxins becomes particularly useful for his inclusion of
the attribute “extremely complex.” Not every toxic substance falls under the category of
toxin because some are simply too small, uncomplicated, or mundane. This is not to say
that small molecules cannot be toxic, but rather that they must be defined as something
other than toxins. This distinction is useful because small molecules and inorganic
compounds appear to be incapable of achieving the degree of toxicity seen in the most
potent proteic toxins:
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Table 1.1
Properties of selected substances toxic to eukaryotes.a

(Ferrier, 1985)(Santhakumar, Wallner & Otis, 2007)(Meneely et al., 1953)(Trost & Lemasters, 1997)(Barbier, Arreola-Mendoza & Del Razo, 2010)(Wallace & Starkov, 2000)(Hughes, 2002)(Carvalho et al., 2008)(Rocha, Ansari & Doohan, 2005)(Gupta, 2009)(MacKintosh et al., 1990)(Catterall et al., 1981)(Saxena, O’Brien & Ackerman, 1989)(Honjo et
al., 1968)(Endo et al., 1987)(Humeau et al., 2000)

a

The doses required for lethality in 50% of test subjects (LD50) given are from studies of toxicology in
mice and rats. Molality is calculated here by making the simplifying assumptions that the entire mass of
cells and their interstices may be considered solvent, that this solvent has a density equal to that of water,
and that all of the listed compounds distribute evenly to the intracellular and extracellular fluids. The
number of molecules per cell is calculated by assuming an average cell volume of 4,000 cubic microns,
which agrees with many published reports of various eukaryotic cell types.
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The most toxic known members of several families of molecules are included in Table
1.1. Those families are, in order of increasing toxicity: inorganic salts, organic molecules
of intermediate size, and proteins. It is readily apparent that on a molar basis botulinum
toxin, the most potent proteic toxin known, is more than 400,000-fold more toxic than
batrachotoxin, one of the most toxic alkaloids known. Batrachotoxin, in turn, is about
1,000-fold more toxic than mercury (II) chloride, one of the most toxic inorganic salts.
This trend is reflective of our understanding that increased structural complexity allows
for increased functional complexity. This may be illustrated by a comparison of the
effects of tetrodotoxin and botulinum toxin. Both toxins achieve the same end: blocking
the transmission of nerve signals. However, they achieve this effect by different means.
Tetrodotoxin directly blockades sodium channels and must remain bound in order to
function as a toxin. One equivalent of tetrodotoxin inactivates one equivalent of sodium
channels. On the other hand, botulinum toxin is an enzyme that recognizes and cleaves
several different protein factors required for neurotransmitter release. A single molecule
of botulinum toxin can inactivate many neurotransmitter-laden vesicles from within the
cell, resulting in a profound amplification effect. Botulinum toxin also possesses
domains that determine its localization with respect to tissues and cells, targeting it
specifically to nervous tissues and preventing its dissipation across unaffected tissues and
compartments. A rough correlation between the complexity of toxins and their potential
lethality may be observed if the concentration of the lethal dose to 50% of test subjects
(LD50) is plotted against molecular weight, which is used here as a rough approximation
of complexity:
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Figure 1.1 – Plot of the molality at LD50 versus molecular weight for the most toxic proteins,
alkaloids, organophosphate, and inorganic salts known. If molecular weight is assumed to roughly
approximate molecular complexity, a strong correlation exists between the complexity and the maximum
potential toxicity of any given toxin or toxic substance. This may be explained by structural complexity
potentiating functional complexity. The most potent toxins known are all enzymes, the catalytic activity of
which creates a strong amplification effect whereas structurally simpler toxins must act at parity against
their targets.
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Small peptide toxins like those found in marine cone snails' venom tend to have
simple mechanisms of toxicity involving ion channel blocking or pore formation, and,
barring a single exceptional superfamily, lack enzymatic activity (Terlau & Olivera,
2004; McIntosh et al., 1995). Size and complexity are required to attain sufficiently
efficient, specific, and stable enzymatic activity (Tiessen, Perez-Rodriguez & DelayeArredondo, 2012). In many cases enzymes must also be large enough to allow for
necessary domains for regulatory interactions. A toxin, likewise, may require domains
dedicated to targeting its localization to and within its target cells, as is seen in both
botulinum toxin and tetanospasmin (Humeau et al., 2000). Depending on their source
and trafficking, other toxins may require proteolytically cleavable domains to permit both
an active toxin and inactive pro-toxin state (Garred, Deurs & Sandvig, 1995).
While greater chemical complexity allows for greater specificity for a given target
macromolecule, it also allows for greater selectivity against nonspecific binding. It is
widely known that the cyanide ion inhibits cytochrome C oxidase to poison
mitochondrial electron transport, but less well known is that the cyanide ion is a general
inhibitor of all heme-containing enzymes, many of which are more immediately
dispensable than those of the electron transport chain (Wallace & Starkov, 2000).

1.2 Toxicants
The simplest toxic byproducts of fungal and bacterial primary metabolism are not
toxins because they lack both the complexity and toxicity to be classed as such. They are
more appropriately categorized simply as toxicants. However, these products of bacterial
and fungal metabolism do in some cases find a role in denying resources to competing
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organisms by gross modification of the local environment. For example, Saccharomyces
species are known to exhibit the Crabtree effect, through which their aerobic glycolytic
pathways are inhibited, despite an abundance of oxygen, and aerobic fermentative
mechanisms rapidly convert sugars to ethanol in the presence of high concentrations of
fermentable sugars (Thomson et al., 2005). This process results in the exclusion of other
fungal and bacterial species from the nutrient-rich environment by conversion of sugars
to alcohols that are suitable for later use by Saccharomyces but not its competitors
(Postma et al., 1989).

1.3 The Lower Limits of Size and Complexity for Toxins
Lipopolysaccharides (LPS) from bacteria and alkaloids from plants may be considered
perhaps the smallest and least complex of the toxins, along with some of the simpler
peptide toxins from kingdom Animalia and nonribosomal peptides (NRPs) from bacteria
and fungi. Lipopolysaccharides (LPS) are capable of exerting potent toxic effects despite
their relatively low molecular weight and complexity compared to proteic toxins. The
best characterized LPS, Lipid A, is known to be capable of triggering an acute immunemediated systemic shock reaction (Chilton, Embry & Mitchell, 2012). Alkaloids are also
small and relatively noncomplex, but unlike LPS alkaloids span a broad gamut of
structural motifs with over 12,000 unique compounds currently known (Crozier, Clifford
& Ashihara, 2008). NRPs are generally small with respect to proteins, but can still be
quite complex. Cyclization, uncommon amino acids, and types of functionalization not
observed in proteins are all commonly seen in NRPs (Strieker, Tanović & Marahiel,
2010).

7

1.4 Antibiotics
Several drugs used in medicine and research are NRPs, including the
antimycobacterials daptomycin and capreomycin, the antibacterials bacitracin A and
polymixin B, and the immunosuppressant cyclosporine. However, many of the
antibiotics in current clinical use belong to other classes of compounds—penicillins,
cephalosporins, carbapenems, aminoglycosides, macrolides, and tetracyclines, all of
which were originally discovered as natural products produced by bacteria or fungi
(Foye, Lemke & Williams, 1995).
Microorganisms use antibiotics to kill or incapacitate nearby competing
microorganisms (Williams et al., 1989). In the sense that they are selectively poisoning
their local environment to effect area denial, this strategy resembles the alcoholproducing behavior of Saccharomyces. However, whereas ethanol is inhibitory for some
microorganisms at concentrations as low as 1.3 grams per liter (about 0.1% volumetric,
or 0.2 proof by a brewer’s reckoning), susceptible streptococcal strains are found to be
inhibited by less than 2 milligrams of penicillin per liter, representing a 650-fold greater
sensitivity (Chatterjee et al. 2006; Weinstein, Klugman, & Jones 2009). In fact, some
bacterial species are capable of exponential growth at ethanol concentrations of up to 50
grams per liter (about 6.3% volumetric, or 12.6 proof) while others are susceptible to
penicillin at concentrations of 30 micrograms or less per liter, representing a 1.7 millionfold differential in toxicity (Sawada & Nakamura 1987; Weinstein, Klugman, & Jones
2009).
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The vast difference in the susceptibility of bacteria to ethanol and penicillin is
explained by the macromolecules and complexes targeted by each. Ethanol owes its
antibacterial properties to its ability to denature proteins and disrupt membranes, nonspecific activities which may require significant concentrations (McDonnell & Russell,
1999). Penicillin affects a number of diverse targets in susceptible bacteria, but its
primary effects are seen in its ability to inhibit transpeptidases required for synthesis of
peptidoglycan, thus weakening the cell wall and ultimately leading to lysis (Kohanski,
Dwyer & Collins, 2010). Other antibiotics exhibit similar specificity in targeting.
Perhaps most intriguing about naturally-occurring antibiotics is the length that any
given organism must go to in order to synthesize them. Erythromycin production in
Streptomyces species requires twenty-one separate enzymes for synthesis of the molecule
and there exists a separate mechanism to protect the bacterium’s own protein translation
machinery from the drug prior to export from the cell (Challis & Hopwood, 2003).
Natural selection in intensely competitive environments like soil guides the design of
antibiotics in modular synthesis systems to yield powerful antimicrobials (Williams et al.,
1989; Xue & Sherman 2000). The chemical evolution of antibiotics does not end with
the struggles of the bacterium and its enemies in isolation, though, because in some
ecosystems an additional level of selection is imposed by higher organisms.
Leaf cutter ants of the genus Acromyrmex are known to carry filamentous, antibioticproducing Actinomyces cultures on the exterior of their exoskeletons. These cultures
reside in different locations on different species of Acromyrmex and are transmitted
vertically to the ants’ progeny. The ants, their actinomycete passengers, and the fungus
they farm form a tripartite mutualism in which the fungus feeds the ants, the ants groom
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the fungus, and the actinomycetes produce antifungals capable of inhibiting growth of
Escovopsis, a persistent pest of Acromyrmex fungal gardens (Currie et al., 1999). More
interesting yet is the observation that the particular mutualistic bacteria and their
antibiotics observed in association with the ants suggests that not only is the expected
coevolution occurring, but also that the ants are actively sampling and selecting cultures
from the environment that give them an advantage against their gardens’ Escovopsis
parasite (Barke et al., 2010). If it holds, this finding would explain one of the
fundamental problems of understanding leaf cutter ant ecology: how does the
actinomycete–ant mutualism persist in the face of the continuous evolution of antifungal
resistance in Escovopsis (Mueller et al., 2008)?

1.5 Proteic Toxins
Ants and their gardens, however, are not the only creatures with need for chemical
fences and lances. Plants, animals, and bacteria alike have evolved proteic toxins of
varying sizes and complexity. Organisms primarily use proteic toxins as aids in one or
both of two activities: predation or defense against predation. The use of venom for
predation has been observed in mammals (Ellis & Kraver, 1955), reptiles (Fry et al.,
2009), molluscs (Olivera, 2006), and worms of the phyla Nemertea (Kem et al., 2006),
Polychaeta (Morel, Thieffry & Manaranche, 1983), and Chaetognatha (Thuesen et al.,
1988), among others. Marine snails of the genus Conus are particularly noted for
possessing a surprising array of small peptide toxins in their venoms, with an estimated
70,000 unique peptide toxins found across 700 known species (Olivera, 2006). While
most species of hymenopteran fit this pattern of strictly predatory or defensive
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employments of toxins, there are certain wasp species that use toxins to paralyze prey for
the purpose of parasitoid reproduction rather than simple predation (Libersat & Gal,
2013).
Bacteria also employ toxins for various purposes, including competition among
themselves. Bacteriocins are a group of structurally and functionally diverse bacterial
toxins used to kill other bacterial species or strains (Riley, 1998). Colicin E3, for
example, is expressed and secreted by a strain of colicin-insensitive E. coli to kill
competing colicin-sensitive E. coli by cleavage of the 16s ribosomal RNA after receptormediated translocation across the bacterial cell membrane (Chao & Levin, 1981). Other
proteic toxins of bacteria have a role in defense against predation by protozoans. Both
diphtheria toxin and shiga toxin have been shown to kill predatory amoeba that ingest
toxin-expressing bacteria, though the toxins have no effect when simply added to growth
medium (Arnold & Koudelka, 2014). Interestingly, these toxins are encoded on plasmids
rather than in the bacterial chromosome and are important in the pathology of several
clinically significant infectious diseases. While some phage-encoded toxins have been
shown to mediate certain bacterial species' and strains' ability to damage host cells, other
phage-encoded toxins appear to operate wholly within the bacterium harboring their
plasmid.

1.6 Toxin-Antitoxin Systems
Some bacteriophage make effective use of a pairing of an stable antibacterial toxin
and its unstable cognate antitoxin by encoding them in their plasmids, thus preventing the
survival of plasmid-free daughter cells and greatly reducing the frequency of plasmid loss
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(reviewed by Yamaguchi, Park & Inouye, 2011). This is perhaps only the most obvious
role of toxin-antitoxin (TA) systems, and other functions including bacterial persistence,
survival under starvation conditions, post-transcriptional regulation, and general
regulation of cell growth have been suggested (Magnuson, 2007; Tsilibaris et al., 2007).
There are presently five classes of TA systems documented in the literature. All five
types employ proteic toxins, though it is sometimes claimed that the mRNA of certain
systems is toxic despite the fact that in all cases toxicity is mediated by the actions of the
encoded protein toxin (Goeders & Van Melderen, 2014). Type I and III antitoxins are
RNAs. Type I antitoxins are complementary to their toxin's mRNA and thus duplex with
it, inhibiting translation and ultimately triggering degradation (Fozo, Hemm & Storz,
2008). Type III antitoxin RNAs contain sequences recognized and bound by their cognate
protein toxins, sequestering the toxin (Blower et al., 2012). Type II, IV, and V systems
employ proteic antitoxins. Type II antitoxins directly bind and sequester their cognate
toxins (Leplae et al., 2011). The sole Type IV antitoxin described, AbiEi, directly
interacts with the toxin's target to compete for the toxin's binding site on the target
without any direct interaction with the toxin itself (Dy et al., 2014). The sole Type V
antitoxin described, GhoS, is an RNAse that degrades the toxin's mRNA prior to
translation (Cheng et al., 2014).

1.7 The Doc Toxin
The focus of this thesis project has been a study of the mechanism of action of the Doc
toxin of the Phd-Doc Type II TA system of the bacteriophage P1. This TA system
functions as a plasmid addiction operon in the wild-type phage, allowing a plasmid
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curing frequency of just 10-5 despite the P1 plasmid's low copy number (Lehnherr et al.,
1993). The Phd antitoxin is a protein 73 amino acids in length that functions both in
neutralizing the toxin by directly binding it and, in complex with the toxin, autoregulating
the toxin-antitoxin operon (Smith & Magnuson, 2004; Magnuson et al., 1996). Two Phd
molecules bind each Doc molecule to form a heterotrimer (Garcia-Pino et al., 2008).
Prior to the start of this project, it was known only that Doc appears to inhibit protein
translation (Hazan et al., 2001). The Woychik lab claimed in 2008 that Doc inhibits
protein synthesis by directly binding to the 30s ribosomal subunit (Liu et al., 2008).
However, the evidence provided to support this claim was the indirect observation that a
certain mutant strain of E. coli is resistant to both Doc and hygromycin B, an antibiotic
that prevents movement of tRNA from the ribosomal A-site to the P-site (Brodersen et
al., 2000). Interestingly, Liu’s observation may indicate that phosphorylation of EF-Tu
results in the same blockade of EF-Tu-bound aminoacyl-tRNA, possibly by blocking
entrance to the A-site or exit from it, or by preventing dissociation of the EF-Tuaminoacyl-tRNA complex. Whatever the meaning of the result, it was not proof of Doc’s
toxicity being due to a direct binding effect on the 30s ribosomal subunit. Shortly
thereafter it was shown that Doc has significant homology to Fic (filamentation induced
by cAMP protein), an AMPylator of Rho family GTPases, suggesting that Doc itself
might be an enzyme (Kinch et al., 2009). This was the state of knowledge regarding
Doc’s mechanism of toxicity at the start of this project.
Shortly before completion of this project, two groups working independently made
new claims, well supported by their data, regarding the molecular mechanism of Doc
toxicity. In December 2013 the Garcia-Pino group claimed that Doc’s toxicity is due to
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specific phosphorylation of EF-Tu (Castro-Roa et al., 2013). In January of 2014 the
Woychik group made an identical claim publishing similar experimental results (Cruz et
al., 2014). Both groups identified the conserved threonine at position 382 on EF-Tu as
the site of phosphorylation.
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CHAPTER 2

MATERIALS AND METHODS

2.1 Bacterial strains, phage, and plasmids.
The bacterial strains, phage, and plasmids used in this project are described in Table
2.1 below. λRDM12 was generated by Dr. Roy Magnuson. XY-series bacterial strains
and pXZ-series plasmids were generated in Dr. Magnuson's lab by his former graduate
student Xueyan Zhao.
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Table 2.1
Bacterial strains, phage, and plasmids used in this project.
Name

Description and/or Construction

Source/Reference

Bacterial Strains
BR6545
(MC1061)

araD139, ∆(ara-leu)7696, ∆lacX74, galUgalK,
hsdR2(rk-mk+), mcrB1, rpsL (StrR)

(Casadaban &
Cohen, 1980)

XY217
(BL21)

E. coli B F-, dcm, ompT, hsdS(rb-mb-), gal,
[malB+] K-12(λS)

(Studier &
Moffatt, 1986)

XY189-4

pXZ60 (PTAC-Met-6His-TEV-phd-doc), pLacIq,
and λRDM12 into BR6545

Lab Collection

XY223

pXZ48 (PTAC-phd-doc-6His) and pLacIq
into XY217

Lab Collection

Phage
λRS45

bla'-lacZsc, imm21 ind+ fusion vector

(Simons, Houman &
Kleckner, 1987)

λRDM12

Pr92 native promoter of phd-doc operon fused
to lacZYA in λRS45

(Magnuson et al.,
1996)

Plasmids
pLacIq

lacIq inserted into pACYC184 at EcoRI

(Kashlev et al., 1990)

pXZ48

phd-doc-6His inserted into pKK223-3 at EcoRI

Lab Collection

pXZ60

Met-6His-TEV-phd-doc inserted into pKK223-3
at EcoRI

Lab Collection
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2.2 Media and culture methods.
Standard Lysogeny Broth (LB, as described in Bertani, 1951 and acquired from Fisher
Scientific) and LB agar was used for culturing and inducing all strains used. Freezer
stocks were made with 25% volume concentration glycerol and stored at -80° Centigrade
(C). Streaks from freezer stocks were performed by scratching the top of the frozen stock
carefully with an autoclave-sterilized wooden stick, then streaking-out the sample on an
LB agar plate with appropriate antibiotics. Plates were grown overnight at 37°C and then
re-streaked from single, well-isolated colonies to fresh LB agar plates with appropriate
antibiotics and grown overnight at 37°C. Single, well-isolated colonies were picked with
autoclave-sterilized wooden sticks and used to inoculate 5 mL of LB broth with
appropriate antibiotics in a glass culture tube. Tubes were rotated in a rotary drum at 30
rotations per minute (rpm) in a 37 degree C incubator overnight. All broth and agar used
was sterilized by autoclaving for 30 minutes at a temperature of 121°C and a pressure of
approximately 105 kiloPascals.
Antibiotics were made as 1,000x stock solutions. 1,000x ampicillin stock was
prepared by dissolving 1g of ampicillin sodium salt (Fisher) in 10 mL of distilled water
(dH2O) for a final stock concentration of 100 mg/mL. 1,000x kanamycin stock was
prepared by dissolving 0.3 g of kanamycin sodium salt (Fisher) in 10 mL of dH2O for a
final stock solution of 30 mg/mL. 1 M isopropyl-β-D-1-thiogalactopyranoside (IPTG,
Fermentas) stock used for induction of protein expression was made by dissolving 2.38 g
of IPTG in 10 mL of distilled water (dH2O). All antibiotic stocks and IPTG were filtersterilized by passage through a 0.2 µm syringe filter (EMD Millipore).
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2.3 Preparation of crude lysates.
A pellet of cells made as described above was thawed on ice and then resuspended in
an appropriate lysis buffer. Typically, 1 µL of 25 unit per µL (U/ µL) benzonase
(Novagen), 10 µL of 100 µg/mL phenylmethylsulfonyl fluoride (PMSF, Sigma)
dissolved in 100% ethanol, and 10 µL of 10 mg/mL lysozyme (Fisher) were added. The
resuspension was mixed briefly by tituration and then separated into 1 mL aliquots in 1.5
mL microcentrifuge tubes. Aliquots were sonicated in an ice and 95% ethanol (AAPER)
bath until the suspension visibly cleared. Aliquots were then centrifuged for 1 hour at
16,000 RCF in a microcentrifuge at 4°C. The precipitate was discarded and the
supernatant was placed on ice or used immediately.

2.4 Dialysis of lysates.
Dialysis tubing (Spectrum Spectra/Por 3,500 MWCO) was prepared by soaking it for
at least one hour in 50 mM EDTA (Fisher) adjusted to a pH of 8.0. The tubing was then
rinsed with excess dH2O. One end of the tubing was closed with two single overhand
knots, carefully pulled tight from the unused open end of the tubing. Solution for dialysis
was then carefully pipetted into the dialysis tubing. The top of the tubing was closed with
knots as described above, carefully leaving a volume equivalent to approximately 20% of
the total solution volume devoid of solution or air. The dialysis tubing was then placed in
a Nalgene bucket of dialysis buffer, a small stirring bar was added, and the bucket was
placed on a stir plate at 4°C with the stirrer turning at a low speed. Dialysis was
performed for 16 to 24 hours between exchanges of buffer.
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2.5 Purification of 6xHis-TEV-Phd and Doc by IMAC on Ni-NTA resin.
XY189-4 cells were streaked from 25% glycerol (Fisher) freezer stocks from a -80°C
freezer to LB agar plates containing 100 µg/mL ampicillin and 30 µg/mL kanamycin.
Plates were grown overnight at 30°C. Single, well-isolated colonies were selected and
streaked onto fresh agar plates as described above and grown overnight. Single, wellisolated colonies were selected and used to inoculate tubes containing 5 mL of LB broth
containing 100 µg/mL ampicillin and 30 µg/mL kanamycin. The inoculated tubes were
incubated overnight at 30°C in a rotary drum at 30 rotations per minute (rpm). The
optical density (OD) of the cultures was measured at 600 nm and 2800 mL Pyrex No.
4420 flasks containing 1 L of LB broth as described above were inoculated with a
calculated 0.0005 absorbance units (AU) of culture. Culture flasks were incubated at
30°C in a water bath shaking at 150 rpm. The optical density of the cultures was
monitored and expression was induced by addition of 1 mL of 1 M IPTG when the
culture reached a density of 0.5. Incubation with shaking was continued as described
above for six hours. The final optical density was recorded and the cells were centrifuged
at 8,000 rpm for 15 minutes at 4°C in a Beckman J2 centrifuge using a JA-14 rotor. The
supernatant was discarded and the cell pellets were frozen at -20°C.
A pellet of cells made as described above was thawed on ice and then resuspended
with 4.5 mL of 1.42 M ammonium sulfate. 1 mL of 25 unit per µL (U/ µL) benzonase
(Novagen), 100 µL of 100 µg/mL phenylmethylsulfonyl fluoride (PMSF) dissolved in
100% ethanol, and 10 µL of 10 mg/mL lysozyme were added. The resuspension was
mixed briefly by tituration and then separated into 1 mL aliquots in 1.5 mL
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microcentrifuge tubes. Aliquots were sonicated in an ice and 95% ethanol bath until the
suspension visibly cleared. Aliquots were then centrifuged for 1 hour at 16,000 RCF in a
microcentrifuge at 4°C. The precipitate was discarded and the supernatant was
transferred to 15 mL Falcon tubes. 550 µL of 4M ammonium sulfate was added per mL
of supernatant to bring the ammonium sulfate concentration up to 2.24 M. Samples were
incubated on ice for 2 hours or at 4°C overnight, then centrifuged at 3,600 rpm at 4°C in
an IEC HN-S centrifuge with an 809 rotor. The supernatant was discarded and the pellet
was stored overnight at -20°C or, for immediate use, was resuspended and dissolved in a
buffer composed of 50 mM tris (Fisher) adjusted to pH 8.0, 300 mM sodium chloride, 2
M guanidine hydrochloride (Acros), 20 mM imidazole (Fisher), and 0.02% mass
concentration of sodium azide (Matheson, Coleman, & Bell).
After dissolving the pellet in the buffer described above, the entire sample was loaded
onto a nickel-nitrilotriacetic acid (Ni-NTA, Thermo Scientific His-Pur resin) column 1
cm in inner diameter and 4.5 cm in length pre-equilibrated with the pellet resuspension
buffer described above. The column was washed with 30 mL or approximately 8 column
volumes (CV) of pellet resuspension buffer. All flow-through was collected as fractions.
Doc was then eluted from Phd with 25 mL or approximately 7 CV of a buffer composed
of 50 mM tris adjusted to pH 8.0, 300 mM sodium chloride, 3.5 M guanidine
hydrochloride, 20 mM imidazole, and 0.02% mass concentration of sodium azide. 6xHisTEV-Phd was then eluted with 25 mL or approximately 7 CV of a buffer composed of 50
mM tris adjusted to pH 8.0, 300 mM sodium chloride, 250 mM imidazole, and 0.02%
mass concentration of sodium azide. The OD at 280 nm (OD280) of the collected
fractions was recorded and fractions were pooled according to peaks of absorbance. The
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pooled fractions were precipitated overnight at 4°C by addition of 0.3 to 0.4 g/mL dry
ammonium sulfate, with sufficient vortexing to fully dissolve the ammonium sulfate.
Overnight precipitations were then centrifuged at 3,600 rpm for 30 minutes at 4°C in an
IEC HN-S centrifuge with an 809 rotor. The supernatant was discarded and the pellet
was resuspended in 0.5 mL of a buffer composed of 50 mM tris adjusted to pH 8.0, 250
mM sodium chloride, and 0.02% mass concentration of sodium azide.

2.6 Purification of Phd and Doc-6xHis by IMAC on Ni-NTA resin.
XY223 cells were streaked from 25% glycerol freezer stocks from a -80°C freezer to
LB agar plates containing 100 µg/mL ampicillin and 30 µg/mL kanamycin. Plates were
grown overnight at 30°C. Single, well-isolated colonies were selected and streaked onto
fresh agar plates as described above and grown overnight. Single, well-isolated colonies
were selected and used to inoculate tubes containing 5 mL of LB broth containing 100
µg/mL ampicillin and 30 µg/mL kanamycin. The inoculated tubes were incubated
overnight at 30°C in a rotary drum at 30 rotations per minute (rpm). The optical density
of the cultures was measured at 600 nm and 1 L flasks of LB broth were inoculated as
described in section 2.5 above. Culture flasks were incubated at 30°C in a water bath
shaking at 150 rpm. The optical density of the cultures was monitored and expression
was induced by addition of 1 mL of 1 M IPTG when the culture reached a density of 0.5.
Incubation with shaking was continued as described above for six hours. The final
optical density was recorded and the cells were centrifuged at 8,000 rpm for 15 minutes
at 4°C in a Beckman J2 centrifuge using a JA-14 rotor. The supernatant was discarded
and the cell pellets were frozen at -20°C.
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A pellet of cells made as described above was thawed on ice and then resuspended
with 4.5 mL of 1.42 M ammonium sulfate. 1 mL of 25 unit per µL (U/ µL) benzonase,
100 µL of 100 µg/mL (PMSF) dissolved in 100% ethanol, and 10 µL of 10 mg/mL
lysozyme were added. The resuspension was mixed briefly by tituration and then
separated into 1 mL aliquots in 1.5 mL microcentrifuge tubes. Aliquots were sonicated in
an ice and 95% ethanol bath until the suspension visibly cleared. Aliquots were then
centrifuged for 1 hour at 16,000 RCF in a microcentrifuge at 4°C. The precipitate was
discarded and the supernatant was transferred to 15 mL Falcon tubes. 550 µL of 4M
ammonium sulfate was added per mL of supernatant to bring the ammonium sulfate
concentration up to 2.24 M. Samples were incubated on ice for 2 hours or at 4°C
overnight, then centrifuged at 3,600 rpm at 4°C in an IEC HN-S centrifuge with an 809
rotor. The supernatant was discarded and the pellet was stored overnight at -20°C or, for
immediate use, was resuspended and dissolved in a buffer composed of 50 mM tris
adjusted to pH 8.0, 300 mM sodium chloride, 1.2 M guanidine hydrochloride, 20 mM
imidazole, and 0.02% mass concentration of sodium azide.
After dissolving the pellet in the buffer described above, the entire sample was loaded
onto a Ni-NTA column 1 cm in inner diameter and 4.5 cm in length pre-equilibrated with
the pellet resuspension buffer described above. The column was washed with 30 mL or
approximately 8 column volumes (CV) of pellet resuspension buffer. All flow-through
was collected as fractions. Phd was then eluted from Doc-6xHis with 25 mL or
approximately 7 CV of a buffer composed of 50 mM tris adjusted to pH 8.0, 300 mM
sodium chloride, 3.5 M guanidine hydrochloride, 20 mM imidazole, and 0.02% mass
concentration of sodium azide. Doc-6xHis was then eluted with 25 mL or approximately
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7 CV of a buffer composed of 50 mM tris adjusted to pH 8.0, 300 mM sodium chloride,
250 mM imidazole, and 0.02% mass concentration of sodium azide. The OD280 of the
collected fractions was recorded and fractions were pooled according to peaks of
absorbance. The pooled fractions were precipitated overnight at 4°C by addition of 0.3 to
0.4 g/mL dry ammonium sulfate, with sufficient vortexing to fully dissolve the
ammonium sulfate. Overnight precipitations were then centrifuged at 3,600 rpm for 30
minutes at 4°C in an IEC HN-S centrifuge with an 809 rotor. The supernatant was
discarded and the pellet was resuspended in 0.5 mL of a buffer composed of 50 mM tris
adjusted to pH 8.0, 250 mM sodium chloride, and 0.02% mass concentration of sodium
azide.

2.7 Purification of target by anion exchange on DEAE resin.
A BR6545 freezer stock was streaked on LB agar with no antibiotics and grown
overnight. A single well-isolated colony was picked and restreaked to LB agar, then
grown overnight again. From this plate, a single well-isolated colony was picked and
used to inoculate 5 mL of LB broth with no antibiotics, then grown overnight in a rotary
drum at 30 rpm in a 30 degree C incubator. 1 mL of saturated culture was used to
inoculate 1 L of fresh LB broth with no antibiotics. The culture was grown at 30°C in a
shaking water bath shaking at 150 rpm. The OD600 was monitored and cultures were
placed on ice as soon as 0.5 AU was reached. Cultures were immediately decanted to 250
mL centrifuge tubes and centrifuged at 8,000 rpm for 15 minutes at 4°C in a Beckman J2
centrifuge using a JA-14 rotor. The supernatant was discarded and the cell pellets were
frozen at -20°C.
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A pellet was thawed on ice and resuspended in 1 mL of a buffer composed of 10 mM
tris adjusted to pH 8.0, 0.2 mM EDTA adjusted to a pH of 8.0, 10% volume
concentration of glycerol, and 0.02% volume concentration of sodium azide. To this
resuspension 1 µL of benzonase, 10 µL of 100 µg/mL PMSF dissolved in 100% ethanol,
and 10 µL of 10 mg/mL lysozyme were added. The resuspension was sonicated on ice
until it visibly cleared. The lysate was centrifuged for 10 minutes at 16,000 RCF at 4°C
in a microcentrifuge.
The entire lysate was loaded onto a 5 mL diethylaminoethyl (DEAE) sepharose
column (Pharmacia, Fast Flow) pre-equilibrated with the lysis buffer. The column was
washed with 4 CV of lysis buffer, then an 8 CV gradient from 0-100% concentration of
lysis buffer with 1 M sodium chloride was applied, followed by a 3 CV wash with lysis
buffer with 1 M sodium chloride. Fractions were collected an a chromatogram was
recorded. Fractions were stored at 4°C overnight and analyzed by electrophoresis, assay,
and blotting the next day.

2.8 Acetone precipitation of protein samples for electrophoresis.
Samples were placed in microcentrifuge tubes and mixed with 4 volumes of -20
degree C acetone. Samples were incubated for 10 minutes at -80°C followed by
incubation for 90 minutes or overnight at -20°C and then centrifuged for 15 minutes at
16,000 RCF in a microcentrifuge at 4°C. The supernatant was then carefully discarded,
with particular care taken not to disturb the pellet. The pellet was dried in the hood with
the microcentrifuge tube caps open until all traces of acetone were gone.
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2.9 Trichloroacetic acid precipitation of protein samples for electrophoresis.
Samples were placed in microcentrifuge tubes and mixed with 3 volumes of ice-cold
20% mass concentration trichloroacetic acid (TCA, Acros). Samples were then incubated
for 5 minutes at -20°C and then for at least 15 minutes on ice, then centrifuged for 15
minutes at 16,000 RCF in a microcentrifuge at 4°C. The supernatant was then carefully
discarded, with particular care taken not to disturb the pellet. The pellet was then washed
with 2 volumes of -20°C 100% ethanol and dried in the hood with the microcentrifuge
tube caps open.

2.10 SDS-PAGE gel electrophoresis.
SDS-PAGE was performed in accordance with Laemmli's method (1970) modified by
use of Bis-Tris gels and MES buffer system (Invitrogen). Samples were first prepared, if
necessary, by TCA precipitation to remove excess unincorporated radiolabeled ATP,
guanidine, or salts, or to concentrate dilute samples. Sample volumes were brought up to
10 mL volume and 1x concentration of NuPage LDS Loading Buffer (Invitrogen) from a
4x NuPAGE LDS Loading Buffer stock to which a 4% volume concentration of βmercaptoethanol (BME) was added. Samples were mixed by careful tituration and special
care was taken to ensure that precipitated samples were dissolved. Samples were then
denatured for 10 minutes in a 90 degree C water bath. Samples were then centrifuged for
3 minutes at 16,000 RCF in a microcentrifuge.
12% NuPage Bis-Tris pre-cast gels were prepared by removing the comb and adhesive
plastic strip. Gels were clamped to the gel running apparatus and the reservoirs were
filled with 1x NuPage MES Running Buffer made from a 20x stock solution (Invitrogen)
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and checked for leaks. Samples were then loaded onto the gel and electrophoresed at 75
to 100 volts direct current (VDC) for 160 volt-hours (V-hrs) or until the blue loading dye
cleared the bottom of the gel.

2.11 2D-PAGE gel electrophoresis.
2D-PAGE electrophoresis was done in accordance with O’Farrell's method (1975).
Isoelectric focusing (IEF) tube gels were prepared according to manufacturer's
instructions (Bio-Rad Protean II xi) using Bio-Lyte 4/6 ampholytes (Bio-Rad). Tube gels
were mounted in the apparatus and it was checked for leaks. 20 mM sodium hydroxide
(Fisher) dissolved in dH2O was used as the cathode buffer in the upper reservoir chamber
and 10 mM phosphoric acid (Fisher) was used as the anode buffer in the lower reservoir
chamber. Neither solution's pH was adjusted. Samples were denatured by addition of a
freshly made sample buffer containing 100 mM DTT (Fluka), 7% mass concentration
CHAPS (Sigma), 12 M urea (Sigma), and 7% volume concentration Bio-Rad Bio-Lyte
4/6 ampholyte solution. Samples were then incubated at 95°C for 5 minutes to denature.
Samples were loaded onto the first dimension tube gels and run for 2 hours at 200 VDC,
then 2 hours at 500 VDC, and then finally overnight at 800 VDC. The second dimension
12% SDS-PAGE slab gel was poured as described in the manual and allowed to
polymerize overnight. Tube gels were extruded and soaked briefly in a transfer solution
composed of 2% mass concentration SDS (Fisher), 70 mM Tris-HCl pH 8.8, and 0.001%
volume concentration bromophenol blue. Extruded tubes were then carefully laid over the
top of the slab gels and fixed in place with 0.25% mass concentration agarose in stacking
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gel buffer. Gels were then run at constant 24 mA current for 5 hours, when the dye front
reached the bottom of the gel.

2.12 Rapid coomassie blue staining of PAGE gels.
Coomassie staining was done by modification of Meyer and Lamberts' method (1965),
omitting all organic washes. Gels were removed from their casting frames and marked for
orientation by notching a corner of the gel, if necessary. They were then washed 3 times
for 1 min in 75 mL of dH2O heated in the microwave to approximately 90°C. Washed
gels were then stained for 5 minutes in 50 mL of SimplyBlue SafeStain (Invitrogen)
followed by destaining overnight with room-temperature dH2O water or for 5-10 minutes
with dH2O heated in the microwave to approximately 90°C. Small pieces of folded paper
towels were added to the destaining dH2O to bind free stain.

2.13 Silver staining of PAGE gels.
Silver staining was done by modification of Kerényi and Gallyas method (1973). Gels
were washed in a fixer composed of 50% volume concentration of methanol (Fisher),
12% volume concentration of glacial acetic acid (Fisher), and 0.05% volume
concentration of formalin (Fisher) for 2 hours or overnight. They were then washed 3
times in 35% volume concentration ethanol for 20 minutes, followed by a 2 minute wash
in a sensitizer solution composed of 0.02% mass concentration of sodium thiosulfate
(Sigma). Gels were then washed 3 times in dH2O for 5 minutes. Gels were then soaked in
0.2% mass concentration silver nitrate (Acros) solution with 0.076% volume
concentration of formalin. Gels were then washed twice in dH2O for 1 minute. Gels were
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then developed in a developer composed of 6% mass concentration of sodium carbonate
(Fisher), 0.05% volume concentration of formalin, and 0.0004% mass concentration of
sodium thiosulfate until acceptable band intensity was achieved or background staining
began to overdevelop. Developed gels were then washed in a stop bath composed of 50%
volume concentration of methanol and 12% volume concentration of glacial acetic acid
for 5 minutes. Developed gels were stored at 4°C in a 1% volume concentration of glacial
acetic acid.

2.14 PAGE gel drying.
After gels were fully destained, they were placed on heavy chromatography paper
(Fisher 05-714-4), the paper was labeled, and the tops of the gels were covered with a
sheet of plastic cling wrap. The gels were then placed in a Savant EC355 heated vacuum
dryer on top of another sheet of chromatography paper, then a textured plastic sheet was
laid on top of the assembly with textured surface down. The gel dryer’s silicone cover
sheet was then laid over the gels and the vacuum was applied. The dryer’s heater controls
were set to 80°C and the timer was set for 45 minutes. After the gels were completely
dried they were stored pressed between heavy books on a flat surface for several days,
and then pasted and taped them into a lab notebook or stored under a flat weight.

2.15 Western blotting.
Squares of filter paper and nitrocellulose membrane with 0.45 µm pore size (S&S NC)
were soaked in a blotting buffer composed of 25 mM tris base, 192 mM glycine (Fisher),
10% volume concentration of 95% ethanol, and 0.05% mass concentration of sodium
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dodecyl sulfate (SDS, Fisher) with no adjustment of the pH of any component or the final
buffer. Samples for blotting were separated by SDS-PAGE as detailed in section 2.10
above. Gels were removed from their cassettes and placed on pre-soaked nitrocellulose
membranes carefully so as to avoid creating bubbles between the gel and membrane.
Layers of pre-soaked filter paper were added to each side of the gel-membrane stack,
again careful to avoid introducing bubbles. The filter paper-gel-membrane-filter paper
stacks were then placed in a blotting apparatus (Bio-Rad Mini Trans-Blot) in the correct
orientation so that protein would transfer out of the gel and directly onto the membrane.
The apparatus was filled with blotting buffer, loaded with a frozen cold-pack, and
assembled with a magnetic stir bar in the bottom. It was placed on a stir plate set to spin
at 150 rpm and the transfer was carried out at with a maximum current limit set at 100
mA and a maximum voltage limit set at 100 VDC for 60 minutes.
Gels were stained with SimplyBlue SafeStain as described above to detect residual
protein in the gels (section 2.12 above). Blots were rinsed 3 times for 1 minute each in a
washing buffer composed of 10 mM tris adjusted to a pH of 7.5, 150 mM sodium
chloride, and 1% volume concentration of octyl phenol ethoxylate (Triton X-100, Sigma).
They were then rinsed 3 times with dH2O briefly and then soaked for 5 minutes in a
0.11% mass concentration of Ponceau S (Sigma) stain dissolved in 1% volume
concentration of glacial acetic acid. The stained blot was then washed twice for 5 minutes
in 5% volume concentration of glacial acetic acid, rinsed with dH2O, and photographed.
The blot was then blocked for at least 30 minutes at 25°C or overnight at 4°C in
washing buffer with 0.5% mass concentration of bovine serum albumin (BSA, Fisher).
The blot was then washed 3 times for at least 1 minute in washing buffer. Primary
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monoclonal mouse anti-EF-Tu antibody (Hycult, HM6010) was then bound for 30
minutes at 4°C at a 1:5,000 dilution in a binding buffer composed of 10 mM tris adjusted
to a pH of 7.5, 150 mM sodium chloride, and 0.02% mass concentration of sodium azide.
The primary antibody was recovered and the blot was then washed at least 5 times for at
least 5 minutes with washing buffer. Secondary polyclonal goat anti-mouse antibody
conjugated with horseradish peroxidase (Invitrogen, G21040) was then bound for 30
minutes at 25°C or overnight at 4°C at a 1:5,000 or 1:10,000 dilution in binding buffer.
Secondary antibody was then recovered and blots were washed at least 5 times for at least
five minutes in washing buffer containing no sodium azide. Blots were briefly rinsed with
dH2O.
5 mL of each component of the Pierce SuperSignal West enhanced
chemiluminescence (ECL) detection kit were mixed in a 15 mL conical tube. The blot
was then soaked for 5 minutes in this solution. The blot was then placed between two
sheets of plastic wrap and then laid directly on film to create exposures in the darkroom.
Exposures of different durations were performed and developed using the method
described in section 2.18 below.

2.16 Enzymatic assays.
A dry aluminum block sample heater was pre-heated to 37°C. A tube of cold 20%
mass concentration TCA was placed on ice and positioned near the sample heater. All
required master mixes were prepared, except that γ-32P-ATP (Perkin Elmer EasyTides 1.6
uM solution, 6,000 Ci/mmol) and unlabeled ATP were not yet added. Reactions were
aliquoted into tubes and any additional components required were added. γ-32P-ATP and
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ATP were mixed, if necessary, and added to reaction tubes by pipetting onto the sides of
the microcentrifuge tubes such that the ATP droplet did not contact the aliquotted master
mix. All samples were placed in a microcentrifuge, the microcentrifuge was pulsed until
it reached full speed then allowed to decelerate, and the experiment timer was started. All
samples were immediately placed in the sample heater. Samples were incubated for the
specified duration then quickly quenched and precipitated by the addition of 3 volumes of
ice-cold 20% TCA. All samples were then incubated on ice and a TCA precipitation was
carried out as described above, discarding all supernatants contaminated with γ-32P-ATP
into appropriately labeled and shielded waste containers.

2.17 Immunoprecipitation.
20 µL of recombinant protein A-sepharose resin (Invitrogen, 101141) was bound to 10
µL of either relevant or irrelevant antibody for 1 hour at 25°C and then washed 3 times
with 180 µL of a washing buffer composed of 10 mM tris adjusted to a pH of 7.5, 150
mM sodium chloride, and 0.02% mass concentration of sodium azide. Either unreacted
protein samples or Doc-modified assay samples were then bound to the resin-bound
antibody for 1 hour at 25°C. The resin was then washed 5 times with180 µL of a radio
immunoprecipitation assay buffer (RIPA) composed of 50 mM tris adjusted to pH 8.0,
150 mM sodium chloride, 1% volume concentration of octyl phenoxypolyethoxylethanol
(Nonidet P-40), 0.5% mass concentration of sodium deoxycholate, and 0.1% mass
concentration of SDS. If unreacted protein sample was used, the immunoprecipitation
was then washed several times with 180 µL of washing buffer and then the assay was
carried out, followed by several final washes with 180 µL of RIPA.
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Immunoprecipitations were then denatured by addition of 10 µL of SDS-PAGE loading
buffer (see section 2.10 above) and incubation for 10 minutes at 90°C. Samples were then
separated on SDS-PAGE and stained with coomassie brilliant blue or silver (sections
2.12 and 2.13 above).

2.18 Autoradiography.
The dark room safelights were turned on to warm up and all standard white room
lights were turned off. Once the safelights were sufficiently bright to see the work area, a
sheet of film (Kodak Biomax XAR-2) was removed and cut into 2 or 4 pieces, depending
on the size and shape of the gel to be autoradiographed. The dried gel was carefully laid
flat against the film and taped in place. Marks were made to note the alignment and
orientation of the gel with a permanent marker directly on the film away from the area to
be exposed. The experimenter’s initials and the date of the exposure were also recorded
directly on the film and any markers visible through the film were marked. A second
sheet of film was laid on top of the first sheet of film and marked. The assembly was
placed in a film cassette with the film facing the intensifier screen. A second sheet of film
was placed directly over the first sheet of film (not over the gel) and the positions of
molecular weight markers and any witness marks were transferred with a permanent
marker. The cassette was closed and latched, and a piece of lab tape was placed across
the latch and marked with the experimenter’s initials and the experiment date. Film was
then exposed for a period ranging from 12 hours to 10 days, depending on the strength of
the signal, either at room temperature or at -80°C.
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The dark room safelights were turned on and allowed to warm up. The developing
trays were rinsed with dH2O and set in the sink basin. The dark room door was secured
and all normal white lights were turned off. The trays were filled with chemicals in their
proper sequence, which is developer first (Kodak Carestream GBX
Developer/Replenisher stock solution diluted 1:5 in dH2O), then a dH2O wash, and
finally the fixer (Kodak Carestream GBX Fixer/Replenisher stock diluted 1:5 in dH2O).
The autoradiography cassette was opened and one sheet of film was removed carefully so
as not to disturb the second sheet taped to the dried gel. The cassette was secured and
placed back in its drawer. The film was placed in the developer and gently agitated by
slowly tilting one edge of the tray up and down. The film was developed for 10 seconds
to 1 minute, watching for dense gel bands to appear. The film was transferred
immediately to the dH2O wash and agitated gently for at least 30 seconds. It was then
rinsed under excess flowing dH2O. The film was then placed in the fixer and gently
agitated for at least 1 minute. Both surfaces of the film were then rinsed thoroughly with
dH2O before hanging the film to dry. All developing chemicals were then poured back
into their appropriate amber bottles, taking care to rinse the funnel before each transfer to
avoid contamination. The developing trays were then rinsed thoroughly and propped
against the basin to dry.

2.19 LC-MS/MS mass spectrometry.
Sample tubes were rinsed twice with acetonitrile, flicked out, and then rinsed once
with USP-grade ethanol before air-drying. Samples for analysis were run on a 12%
NuPAGE SDS-PAGE gel, stained with coomassie brilliant blue, excised with a razor
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blade, and placed in the prepared sample tubes. Samples were then placed on dry ice and
mailed overnight to the University of Alabama in Birmingham's (UAB) Targeted
Metabolomics & Proteomics Laboratory (TMPL). The remainder of the procedure was
performed by UAB TMPL's Landon Wilson, who kindly provided the following details.
Digests and sample preparation were carried out as described below (Kinter &
Sherman, 2000 pp.153-160). Solutions were prepared fresh with nanopure water. A wash
solution of 50% volume concentration methanol and 5% volume concentration acetic
acid in dH2O was made. Solutions of 100 mM and 50 mM ammonium bicarbonate were
made. 100 mM ammonium bicarbonate with 10 mM dithiothreitol was made. 100 mM
iodoacetamide was made. Trypsin solution was prepared by dissolving 5 mg of
sequencing-grade trypsin in 50 mM of ammonium bicarbonate on ice by tituration. An
extraction buffer was made with 50% volume concentration of acetonitrile and 5%
volume concentration of formic acid in nanopure water.
Samples were washed with 200 µL of wash solution overnight at room temperature.
Wash solution was discarded and 200 µL of acetonitrile was added. Samples were
allowed to dehydrate at room temperature for 5 minutes. Residual acetonitrile was then
discarded and the samples were dried for 3 minutes in a vacuum centrifuge. Dried
samples were then reduced for 30 minutes at room temperature with 30 µL of 10 mM
dithiothrietol in 100 mM ammonium bicarbonate. The reducing solution was then
discarded. Samples were then alkylated for 30 minutes at room temperature with 30 µL of
100 mM iodoacetamide. Alkylating solution was then discarded and 200 µL of
acetonitrile was added to once again dehydrate the samples for 5 minutes. Acetonitrile
was then discarded and the samples were incubated for 10 minutes at room temperature
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in 100 mM ammonium bicarbonate. Ammonium bicarbonate solution was then discarded
and the samples were dehydrated for 5 minutes in 200 µL of acetonitrile. Acetonitrile was
discarded and the samples were again dried for 3 minutes in a vacuum centrifuge.
Samples were covered with 30 µL of a 20 ng/µL trypsin solution and allowed to
absorb it for 10 minutes on ice with occasional vortexing and pulsing in a centrifuge.
Residual unabsorbed trypsin solution was discarded and 5 µL of 50 mM ammonium
bicarbonate was added. The sample was centrifuged for 30 seconds and then placed at
37°C overnight to allow digestion to proceed.
30 µL of 50 mM ammonium bicarbonate was added to the overnight digests in the
morning and incubated for 10 minutes at room temperature with occasional vortexing and
pulsing in a centrifuge. Supernatant was discarded and the sample gel slice was
transferred to a 0.5 mL centrifuge tube. 30 µL of extraction buffer was added and samples
were incubated 10 minutes with occasional vortexing and pulsing in a centrifuge.
Supernatant was collected in a new tube and the extraction was repeated, combining the
extracts to yield 60 µL of extracted sample. Samples were spun in a vacuum centrifuge
long enough to concentrate them to 20 µL.
5 µL aliquots of each digested sample were loaded into an Eksigent Nano
cHiPLC 200µm x 0.5mm ChromXP C18-CL 3µm 120Å reverse-phase trap cartridge at
2 µL/min using an Eksigent autosampler. The cartridge was washed for 4 min with 0.1%
volume concentration formic acid in dH20 and then bound peptides eluted onto an
Eksigent Nano cHiPLC column 75µm x 15cm ChromXP C18-CL 3µm 120Å with a 90
minute linear 5-50% volume concentration acetonitrile gradient in 0.1% formic acid at
300 nl/min using an Eksigent Nano1D+ liquid chromatograph. An AB-SCIEX 5600
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Triple-ToF mass spectrometer then analyzed the eluted peptides from the protein
digest. An ion spray voltage of 2300 V was used along with a declustering voltage of 80
V. Ionspray pressure was 10 psi and curtain gas pressure was 25 psi. An interface heater
temperature of 120°C was used.
The eluted peptides were subjected to a time-of-flight (ToF) survey scan from 4001250 m/z to determine the top twenty most intense ions for MS/MS analysis. Product ion
time-of-flight scans at 50 milliseconds were carried out to obtain the tandem mass spectra
of the selected parent ions over the range from m/z 400-1500. Spectra were centroided
and de-isotoped by Applied Biosystems' Analyst software version TF. A β-galactosidase
trypsin digest was used to establish and confirm the mass accuracy of the mass
spectrometer.
MASCOT database searches were carried out against the E. coli genome on the
UniProt database. The mass tolerances for precursor scans and MS/MS scans were set at
0.05 Daltons. One missed cleavage for trypsin was allowed. A fixed modification of
carbamidomethylation was set for cysteine residues and a variable presence of oxidation
was allowed for methionine residues. Proteins with at least one individual peptide
MOWSE score of greater than 40 were considered significant.
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CHAPTER 3

RESULTS AND DISCUSSION

3.1

Doc is purified by denaturing affinity chromatography.
Previous work has shown that in vitro transcription and translation of doc from a

plasmid in an S30 extract results in phosphorylation of a protein target of approximately
45 kiloDalton (kDa) molecular weight (Cale, 2014). The S30 extract is a rich,
complicated system with many components and therefore many potential interferences
(Kigawa et al., 2004). Doc toxin was expressed and purified in order to permit moving
the reaction into a simpler system not capable of supporting either transcription or
translation.
Doc toxin was purified by denaturing IMAC chromatography on a Ni-NTA resin
as previously described (see section 2.5 above). Untagged native Doc was expressed
along with a 6xHis-TEV-Phd fusion. The His-tagged Phd, complexed with Doc, was
bound to the Ni-NTA resin. The bound protein was thoroughly washed and then
denatured with guanidine hydrochloride to elute the native Doc while leaving the Histagged Phd bound to the Ni-NTA resin:
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Figure 3.1: Sequential elution of Doc and 6xHis-TEV-Phd fusion from Ni-NTA resin. A crude lysate
of induced cells expressing 6xHis-TEV-Phd and Doc was bound to a Ni-NTA resin and thoroughly
washed. Doc was eluted by denaturation of the complex with a guanidine hydrochloride wash, leaving
6xHis-TEV-Phd bound to the column. SDS-PAGE lanes: (1) Novex Sharp molecular weight standard, (2)
crude lysate loaded onto the Ni-NTA column, (3) unbound protein in flow-through buffer during loading,
(4) a sample of the flow-through at the end of washing, (5) Doc eluted by denaturation with guanidine HCl,
and (6) 6xHis-TEV-Phd fusion eluted with 250mM imidazole. (This gel is presented as three aligned panels
to remove multiple distracting lanes.)
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Purification on the Ni-NTA resin allowed tight binding of His-tagged Phd to the resin
as well as tight binding of Phd to Doc. Some Phd and Doc are lost in the flow-through
(lane 3), but sufficient protein is eluted in highly purified form, as shown by the clean
bands at 10 and 12 kDa for 6xHis-TEV-Phd and Doc, respectively (lanes 5 and 6). No
Phd is visible contaminating the eluted Doc (lane 5).

3.2

Purified Doc is active against a target of approximately 45 kDa molecular
weight.
Denaturing chromatography methods can cause loss of activity if proteins are partially

degraded or do not refold properly, particularly in the absence of other proteins (Glover
& Lindquist, 1998). In order to verify the activity of purified Doc, it was used to treat an
S30 extract and compared to an identical sample of S30 extract in which plasmidencoded doc was transcribed and translated in vitro. This experiment was a collaboration
with Stephanie Cale, who also used this result in her thesis (Cale, 2014). The author
provided purified Doc, purified doc-encoding BR7046 plasmid, and guidance on
experimental design and execution. Ms. Cale performed the in vitro transcription and
translation as well as the assay for Doc activity against a target in S30 extract.
Purified Doc was obtained in the experiment detailed in 3.1 above. Plasmid expressing
doc from a PTAC promoter was purified from cultures of strain BR7046. S30 extract was
obtained from Promega (product #L1030). Reactions were carried out in parallel and run
on the same SDS-PAGE gel, which was subsequently dried and autoradiographed:
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Figure 3.2: Purified Doc exhibits the same activity as freshly in vitro transcribed and translated doc.
doc was transcribed and translated from a plasmid in vitro in an S30 extract (lane 4) and, for comparison,
purified Doc was used to treat an S30 extract in the absence of plasmid (lane 6). Four luciferase positive
controls were treated with antibiotics. Autoradiographed SDS-PAGE samples: (2) phd, (3) phd-doc, (4)
doc, (5) doc-H66Y, (6) purified Doc, (7) luc, (8) luc + kanamycin, (9) luc + spectinomycin, (10) luc +
chloramphenicol, (11) luc + erythromycin. This experiment was performed by Stephanie Cale during her
thesis research (Cale, 2014). Molecular weight markers in lane 1 were visible on SDS-PAGE by not on the
autoradiograph, so the dried gel and autoradiograph were aligned and the markers' positions were marked
on the autoradiograph with a permanent marker. Purified Doc toxin was provided by the author.
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The clear meaning of this result is that purified Doc is active and has the same type of
activity as that which is produced by the in vitro transcription and translation of doc. The
reader is cautioned, however, not to attempt to draw any quantitative conclusions from
this result. No evidence is provided that purified Doc is as active as Doc freshly
translated in vitro because this experiment cannot address that question. However, this
experiment does indicate that Doc toxin with some degree of native activity has been
purified and may be used in further experiments to characterize Doc’s requirements for
activity and the identity of its specific target or targets.

3.3

Doc is active against a target present in both a bacterial S30 extract and a
crude bacterial lysate.
Commercially-available S30 extracts are expensive and generally provided in small

volumes. In order to conduct an extensive series of assays searching for the conditions
required for Doc activity and the identity of its target, a less expensive and more readily
available substitute for the S30 extract was desirable. Crude lysates of BR6545, a strain
lacking both prophage and plasmids and containing no source of doc, were tested for
activity to confirm that Doc can modify its target in these complicated, crude target
sources.
Crude lysates were generated as described in section 2.3 above, with a BR6545 cell
pellet dissolved and sonicated 1 mL of a buffer composed of 70 mM phosphate adjusted
to pH 8.0, 30 mM imidazole, 430mM sodium chloride, and 0.03% mass concentration of
sodium azide. Prior to sonication, 1 µL of benzonase, 10 µL of 100 mM PMSF, 10 µL of
10 mg/mL lysozyme, and 10 µL of 1 M magnesium chloride were added. The crude
lysate and S30 extract were used to make samples for enzymatic assays with Doc and γ41
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P-ATP. After incubation of the assays, all samples were precipitated with

trichloroacetic acid (see section 2.9 above) and then run on a 12% SDS-PAGE gel. The
resulting gel was dried and autoradiographed (see sections 2.14 and 2.18 above):
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Figure 3.3: Doc is active against its target in a crude bacterial lysate as well as in an S30 extract.
Doc, ATP, and either a crude lysate or S30 extract are sufficient for activity. Either addition of Mg2+ or
omission of premix enhances activity against S30 extract. (This film is displayed in four panels to remove
distracting lanes and simplify the legend above it. The positions of the nolecular weight markers in lane 1
were transferred to the autoradiograph by aligning the gels and marking the autoradiograph with a
permanent marker.)
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These results show that Doc, ATP, and either a crude lysate as described or an S30
extract are sufficient for activity (lanes 4 and 8). Furthermore, they suggest that the S30
premix, which here is used with both S30 extract and crude lysate in lanes 2 and 7,
suppresses signal visible in the autoradiograph. This suppression may be a manifestation
of one or more of four different effects: 1) enhancement of degradation of the target, 2)
enhancement of dephosphorylation of target, 3) inhibition of Doc-dependent
phosphorylation, or 4) degradation of ATP or GTP by some component of the premix.
While the streaking visible in lane 1 would at first seem to indicate that degradation is
occurring, the author rarely witnessed this effect and found that increasing the
concentration of denaturants in gel loading buffers wholly mitigated the effect. It is more
likely that components in the premix compete for ATP, thus lowering the signal level, or
that some component of the premix activates phosphatases that are present in the S30
extract unless extraordinary measures are taken to remove them (Kang et al., 2000).

3.4

The target of Doc can be partially purified on a weak anion exchange resin.
Once crude lysate had been proven a suitable source of target for assays, simpler

sources yet were desired. Removing components of the target source removes potential
interfering factors (and, it is hoped, does not remove accessory factors required for
activity of the toxin or susceptibility of its target). Given that the ultimate goal of this
project was target identification, a sparser matrix of potential target molecules was
desirable so that mass spectrometry could be effectively used. Since the distribution of
proteins’ isoelectric points follows a bimodal distribution with a minimum of protein
species at an approximate pH of 7.2, anion exchange using a buffer system adjusted to a
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pH of 8.0 should fractionate roughly one half of all protein species present, with unbound
proteins of all isoelectric points expected in the flow-through (Weiller, Caraux &
Sylvester, 2004).
A crude lysate was made from BR6545 cells lysed by sonication in an anion exchange
binding buffer composed of 20 mM tris adjusted to pH 8.0, 0.2 mM EDTA, 10%
glycerol, 0.02% mass concentration of sodium azide, 1 µM GDP, and 1 mM BME. The
crude lysate was bound to a column pre-equilibrated to the same buffer, and then washed
with 5 CV of buffer. A linear gradient was then applied, increasing the sodium chloride
concentration from none to 1 M over the course of 10 CV, followed by a 4 CV wash with
1 M sodium chloride. Fractions were collected throughout the procedure and were then
pooled and assayed for Doc-phosphorylatable target. The following chromatogram and
autoradiograph resulted:
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Figure 3.4: Doc is active against a target in a system partially purified by anion exchange. Anion
exchange chromatography was performed on a crude lysate from BR6545 cells (top). Activity against a
specific target of about 45 kiloDaltons molecular weight was observed in two fractions containing protein
that bound to the anion exchanger and were then eluted with a sodium chloride gradient (middle and
bottom). Fractions were analyzed in the following gel lanes: lane 1, total protein load; lane 2, fraction 4;
lane 3, fraction 5; lane 4, fractions 8,9, and 16; lane 5, fraction 10; lane 6, fractions 11-15; lane 7, fractions
17-19; lane 8, PageRuler+ prestained molecular weight marker; lane 9, fractions 27-28; lane 10, fraction
29; lane 11, fraction 30; lane 12, fraction 31; lane 13, fraction 32; lane 14, fraction 33; lane 15, fractions
34-36; lane 16, fractions 37-39; and lane 17, fractions 40-45. The blue trace in the chromatogram shows
UV absorption at 280nm and the red trace shows conductivity of the eluate. (The chromatogram is given in
three panels because the controller had to be restarted twice during the procedure.)
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This experiment clearly fractionated the lysate, leaving fractions 31 through 36 with
varying levels of active target. The greatest activity is seen in fraction 32, which
corresponds to a small peak on the UV absorbance trace. The activity of fractions 32 and
33 is greater than the activity of the original lysate prior to loading on the column,
indicating either a concentration of the target or the removal of some interfering factor.

3.5

Partially-purified anion exchange fractions containing target reactive to Doc
are also reactive to an anti-EF-Tu monoclonal antibody.
It was suspected that the target could be elongation factor-Tu (EF-Tu) because of its

molecular weight and previous reports that Doc stalls translation without cleaving mRNA
(Hazan et al. 2001, Liu et al. 2008). Since target had already been partially purified and
assessed for activity (see section 3.4 above), the next logical step was to see if Doc
activity and reactivity to a monoclonal antibody against bacterial EF-Tu (Hycult Biotech,
mAb 900) were concentrated in the same fractions during anion exchange.
The same fractions analyzed by assay above were separated on an SDS-PAGE gel,
then transferred to a nitrocellulose membrane and Western blotted. After the transfer and
prior to blotting, a reversible Ponceau S stain was used to visualize proteins on the
membrane:
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Figure 3.5: Doc activity is found in the same fractions and at the same molecular weight as reactivity
to a monoclonal anti-EF-Tu antibody, but not all protein that reacts to the antibody is equally active
as target for Doc. Crude lysate fractionated over a DEAE anion exchange resin was assayed for Doc
activity (top), blotted to nitrocellulose and stained with Ponceu S (bottom), and then Western blotted
(middle). All target modified by Doc elutes in fractions reactive to anti-EF-Tu antibody, but not all protein
stained by the antibody is as readily modifiable by Doc.
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All fractions containing target modifiable by Doc are also reactive to anti-EF-Tu
monoclonal antibody at the same molecular weight as the phosphorylation signal.
However, not all protein stained by the antibody is as readily modifiable. There are two
possible interpretations of this result: 1) the target is not EF-Tu, but co-elutes and runs to
the same apparent molecular weight on SDS-PAGE, or 2) the target is EF-Tu, but
multiple species of EF-Tu exist, have different levels of susceptibility to phosphorylation
by Doc, and elute to different fractions. Measuring the conductivity trace (see section 3.4
above) at fractions 32 and 34-36 reveals that these fractions are eluting at approximate
sodium chloride concentrations of 250 mM and 390 mM, respectively, which represents a
large difference in the charge on EF-Tu at pH 8.0 between the two presumptive species.
If we assume for a moment that the Western blot provides a fair basis for comparison of
EF-Tu concentrations in the fractions, fractions 34-36 appear to have approximately half
as much EF-Tu as fraction 32. Furthermore, and certainly more trustworthy as a measure,
Ponceau S staining of the membrane shows that there is perhaps two- to four-fold more
protein overall, and at least two-fold more protein in the approximately 45 kDa band in
fraction 32 than in fractions 34-36, yet fractions 34-36 exhibit greater absorbance at 280
nm on the chromatogram. This could be explained by the proteins in 34-36 having a
greater overall abundance of aromatic amino acids, but another possible explanation is
that EF-Tu in its less susceptible form is bound to aminoacyl-tRNA, thus providing
additional negative charge to more strongly bind the anion exchanger and more strongly
absorb light at 280 nm.

49

3.6

Doc activity is quenched by 10mM EDTA and enhanced by addition of
PMSF.
Given that a partially-purified system was shown above to yield fractions with varying

reactivity towards anti-EF-Tu antibodies and varying susceptibility to phosphorylation by
Doc, enhanced specific activity was desired in order to produce highly-modified target
for mass spectrometry studies. It was hoped that greater fractional modification of the
target would give a greater chance of identifying a phosphorylated peptide fragment by
tandem mass spectrometry. To that end, reaction conditions were tested in an attempt to
identify optimum reaction conditions. The first obvious test was to see whether divalent
cation was necessary for the reaction by depleting it and adding it back.
A crude lysate was made from BR6545 and split four ways equally. The four volumes
of lysate were dialyzed against overnight twice against one liter of a simple buffer 100
µm PMSF and 1 mM EDTA, 100 µm PMSF only, 1 mM EDTA only, or neither
component. All buffers contained 10 mM phosphate adjusted to pH 8.2 and 100 mM
sodium chloride. Assay samples were made using these dialyzed lysates and EDTA,
magnesium chloride, or calcium chloride were added back prior to starting the reactions.
After separation on SDS-PAGE, the following autoradiograph was recorded:
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Figure 3.6: Doc requires a divalent cation and is quenched by excess EDTA. BR6545 crude cell lysate
was dialyzed against phosphate-buffered saline (PBS) with or without EDTA and PMSF added. Activity of
the dialysate was then assayed after treatment with magnesium, calcium, or EDTA, or no treatment at all.
PMSF enhances activity on its own in PBS. After treatment with EDTA, activity is only observed if
magnesium or calcium is added back to the reaction. In all cases, 10mM EDTA quenches the reaction
altogether.
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In systems with divalent cation depleted to, presumably, only tightly-bound cation
remaining, 10mM EDTA completely quenches activity (lanes 1, 6, 10, and 14),
suggesting that some type of divalent cation is required for Doc to be active or for target
to be susceptible to modification. Addition of magnesium or calcium to lysate in PBS
alone yields a weaker signal (lanes 3 and 4), indicating either that too much divalent
cation reduces activity, or that magnesium and calcium are displacing another more
appropriate cation. There is no activity at all in lysates dialyzed against EDTA (lanes 7
and 15) unless some divalent cation is added back (lanes 8, 9, 16, and 17). Comparing
samples with and without PMSF (lanes 1-4 versus lanes 10-13, and lanes 6-9 versus lanes
14-17) reveals that samples with PMSF have higher signal overall despite identical
relative signal between treatments within a dialysis group, indicating that some PMSFinhibited proteolysis may be occurring in its absence. In summary, divalent cation is
required for activity and sequestration of cation quenches activity, but too much divalent
cation appears to inhibit activity. Proteolysis may be occurring before or after
phosphorylation, and could conceivably be dependent upon it.

3.7

Doc activity is suppressed by ADP but not by GDP.
Nucleotide diphosphates (NDPs) are common cofactors and allosteric regulators of

many different enzymes, including initiation and elongation factors required for protein
synthesis (Polekhina et al., 1996, Panniers & Henshaw 1983).
A BR6545 crude lysate was prepared in a buffer composed of 50 mM tris adjusted to
pH 8.0 and 250 mM sodium chloride and used to create assays samples containing final
concentrations of 19 mM tris adjusted to pH 8.0, 95 mM sodium chloride, 5 mM
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magnesium chloride, 10 mM EDTA, 1 mM GDP, 0.1 mM BME, 32 nM γ-32P-ATP, and
7.4 µM Doc. EDTA, GDP, or magnesium chloride were subtracted from some samples
while 1 mM GDP, 100 µM PMSF, 1 mM ADP, or 10 µM ATP lacking radioisotopic
phosphate at the gamma position were added to others. Samples were separated on SDSPAGE and autoradiographed:
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Figure 3.7: Doc is inhibited by 1 mM ADP but unaffected by 1 mM GDP. BR6545 lysate in trisbuffered saline (TBS) was used to create assay samples with 1 mM GDP, 5 mM magnesium chloride, and
10 mM EDTA. PMSF, ADP, and ATP without a radioisotopic label were added to some samples. The
buffer system and lysate used must have sufficient but not excessive magnesium ion present (lanes 1 and
2). GDP may be omitted without affecting the reaction, but the addition of 1 mM ADP is inhibitory (lanes 3
and 11). The inclusion of 10 µM unlabeled ATP in addition to 32 nM γ-32P-ATP does not significantly
diminish the signal. The molecular weight marker was transferred to the autoradiograph film after
development by aligning the gel with the film and then marking the positions of the bands with a blue
permanent marker.
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The addition of 1mM ADP clearly inhibits the reaction, suggesting that some level of
feedback inhibition may be occurring by ADP occupying the active site, allosterically
altering target conformation, or directly competing with ATP for the active site on Doc.
Changes in the ratio of ADP to ATP have been observed to cause interesting effects on
the activity and directionality of critical systems like ATP synthase (Feniouk, Suzuki &
Yoshida, 2007). The omission of GDP from the reaction (lane 3 versus lane 9) has no
apparent effect on the susceptibility of target to modification. Interestingly, EF-Tu is
known to undergo a large conformational shift upon GDP binding (Song et al., 1999), so
here it is possible that if EF-Tu is, in fact, the target of Doc it is already bound to GDP in
the lysate prior to construction of the assay. It is also possible that a saturating
concentration of ADP competes directly with GDP for binding to an allosteric regulation
site on the target, or with ATP for the active site of Doc.
Adding 10 µM unlabeled ATP on top of the 32 nM γ-32P-ATP does not significantly
diminish activity. If it is assumed that EF-Tu is the target and approximately 1 mg/mL is
present in the lysate, the molar concentration is approximately 22 µM, or about twice as
great as the total ATP present in this sample. It is possible that Doc is efficiently
phosphorylating all target in the sample until it exhausts the supply of ATP. It is further
possible that this reaction occurs rapidly enough to completely exhaust the ATP present
during the span of a short assay. In short, this particular result should be ignored until
higher concentrations of ATP may be considered in a later experiment (see 3.10 below).
Again it is observed that control of divalent cation concentration in the reaction is
important. Addition of extra magnesium appears to slightly reduce activity while
omission of EDTA nearly abolishes activity entirely. It is likely that the ratio of EDTA to
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magnesium ion is critical, but there is also a second interpretation of this result. It is
possible that EDTA is required to sequester some other cationic species that could
potentially be poisoning the activity of Doc or the susceptibility of the target. For
perspective, at a pH of 8.0 EDTA binds magnesium ions with a stability constant KS of
2.5 x 106, 2.0 x 108 for calcium ions, 7.9 x 1011 for iron ions, and 2.0 x 1016 for nickel
ions (Dawson et al., 1986).

3.8

Doc is active in a pH range of at least 6.3 to 8.5 and is relatively
thermostable.
After the necessity of divalent cation buffering and nucleotide cofactor had been

investigated, a test for optimum reaction pH was desired. Many enzymes exhibit pHdependent activity and stability, so it was suspected that Doc and its target might also
require some particular range of pH for optimal activity. It was also considered that the
phosphoryl group covalently bound to target could be acid-labile—especially if the target
is phosphorylated at a basic amino acid (Cieśla, Frączyk & Rode, 2011). Likewise, the
effects of incubation at various temperature were tested to ensure that reactions would be
carried out at an optimum temperature.
Partially purified DEAE fractions (see 3.4 above) were purified a second time over
DEAE anion exchange resin and fractions reactive to both Doc and anti-EF-Tu antibody
were selected for use as the source of target in this experiment. Assay samples were made
to contain 1 mM GDP, 750 nM Doc, 25 mM sodium fluoride, 100 µM BME, 10 µM
unlabeled ATP, and 32 nM γ-32P-ATP, plus 100 mM 2-(N-morpholino)ethanesulfonic
acid (MES) adjusted to pH 6.3 or 100 mM tris adjusted to pH 6.8, 7.4, 8.0, or 8.5. An
identical set of assay samples was constructed omitting the buffer and pre-incubating all
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of the reactants except ATP and γ-32P-ATP for 1 hour at 4, 30, 37, or 42°C. ATP and γ32

P-ATP was added to pre-incubated samples after the pre-incubation period. All samples

were incubated for 30 minutes at 37°C, then quenched by addition of 3 volumes of 20%
mass concentration TCA at 4°C. Samples were precipitated by the TCA method,
separated on SDS-PAGE, and autoradiographed:
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Figure 3.8: Doc and its target are not sensitive to a pH range from 6.3 to 8.5 or to temperatures
ranging from 4 to 42°C for periods up to one hour. Assays were constructed using twice-DEAE purified
fractions containing susceptible Doc target and anti-EF-Tu antibody-reactive protein. All samples
contained 1 mM GDP, 750 nM Doc, 25 mM sodium fluoride, 100 µM BME, 10 µM unlabeled ATP, and
32 nM γ-32P-ATP. Samples made to test pH sensitivity also included 100 MES adjusted to pH 6.3 (lane 5)
or 100 mM tris adjusted to pH 6.8, 7.4, 8.0, or 8.5 (lanes 6-9, respectively). Samples testing temperature
sensitivity omitted the buffer and were pre-incubated for 1 hour at 4, 30, 37, or 42°C (lanes 1-4,
respectively) prior to addition of ATP and γ-32P-ATP. Neither temperature nor pH changes within these
ranges were found to have a significant effect.
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The reaction is not greatly affected by preincubation at 4oC, 30oC, 37oC, or 42oC
(lanes 1-4, respectively). A very slight decrease in signal is observed at 37 and 42°C.
This may simply be experimental noise or evidence of some minor degradation of target
or toxin. It is also unaffected by pH in the range of 6.3 to 8.5 (lanes 5-9, respectively) or
by the presence of either tris or MES. The difference in signal between the 4 degree C
pre-incubation sample and the five buffering samples is most likely attributable to
increased buffering of reaction pH, though it is also possible that the effect is due to
increased ionic strength, but not chelation or precipitation of divalent cations since
neither tris nor MES bind cations with any great affinity (Good et al., 1966).

3.9

The phosphate group transferred from ATP to target by Doc is relatively
stable under the conditions studied.
Once appropriate reaction conditions have been established for an assay, a reaction’s

time dependency may be studied to determine its rate. While in-depth studies of Doc’s
kinetics and equilibria conditions would certainly be interesting, they lie outside the
scope of this work. Nevertheless, in order to achieve high specific activity for the
preparation of mass spectrometry samples, two questions remained to be answered: how
long should reactions be incubated to yield the most heavily-labeled target, and how long
can reactions be incubated before the signal is lost? The intent of these experiments was
to explore both of these questions by examining the signal strength from the reaction over
both long and short time courses.
A short time course experiment was planned to incubate with samples collected at 2,
4, 8, 16, and 32 minutes. 60 µL reactions were made to contain 20 mM tris adjusted to
pH 7.5, 100 mM sodium chloride, 10 mM EDTA, 1 mM GDP, 32 nM γ-32P-ATP, 10 µM
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ATP, 0.1 mM BME, and 200 µM PMSF. One reaction was made with 6.25 ng/µL Doc
and a second was made with 25 ng/µL Doc. Both were incubated at 37°C and samples
were collected at the times specified. All samples were immediately quenched by
precipitation with cold TCA. Samples were separated by SDS-PAGE and then
autoradiographed:
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Figure 3.9: Modification of Doc’s target proceeds steadily over a 32 minute time course. Samples were
made to contain 20 mM tris adjusted to pH 7.5, 100 mM sodium chloride, 10 mM EDTA, 1 mM GDP, 32
nM γ-32P-ATP, 10 µM ATP, 0.1 mM BME, 200 µM PMSF, and either 6.25 ng/µL or 25 ng/µL Doc.
Reactions were incubated at 37°C and samples were collected at 2, 4, 8, 16, and 32 minutes. Docdependent modification of target proceeds as expected of a kinase.
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A longer time course experiment was planned to incubate samples up to 16 hours. The
concentration of target in a twice DEAE purified fraction was estimated to be 0.5 µM
based on comparison with a standard curve of known concentrations of a known protein.
Samples were made to contain 0.5 µM target (substrate), 10 nM Doc, 1 mM GDP, 0.1
mM BME, 5 mM sodium fluoride, 3.5 mM magnesium chloride, 30 mM EDTA, 32 nM
γ-32P-ATP, and 8 nM, 32 nM, 128 nM, or 500 nM unlabeled ATP. All reactions were
incubated at 37°C and samples were collected at 8, 15, 30, 60, 120, 240, 450, and 930
minutes. All samples collected were quenched by immediately freezing them in a block
of ice at -20°C. Samples were separated by SDS-PAGE and then autoradiographed:
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Figure 3.10: Target phosphorylated by Doc is stable for approximately one hour, and then begins to
lose signal intensity. Samples were made to contain 0.5 µM target (substrate), 10 nM Doc, 1 mM GDP, 0.1
mM BME, 5 mM sodium fluoride, 3.5 mM magnesium chloride, 30 mM EDTA, 32 nM γ-32P-ATP, and 8
nM, 32 nM, 128 nM, or 500 nM unlabeled ATP (labeled 1:1, 4:1, 16:1, and 64:1 ATP:ATP* above,
respectively) such that the only variable is the concentration of unlabeled ATP. All reactions were
incubated at 37°C and samples were collected at 8, 15, 30, 60, 120, 240, 450, and 930 minutes. The signal
is relatively unchanged over the course of sixty minutes, but significant loss of signal is observed for longer
time courses.
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Each of the four reactions gave a signal that remained relatively unchanged from 15 to
60 minutes. It is perhaps interesting to consider the persistence of the phosphoryl label on
the target protein over this period in terms of the generation time of its target species, E.
coli. 60 minutes of persistence is, under some conditions and without toxins snarling the
protein synthesis machinery, sufficient for up to four binary fissions of the bacterium.
Each also exhibited significant loss of signal beginning around 240 minutes. The loss
of signal indicates that the phosphoryl group may be lost from the target protein by
simple hydrolysis, or that phosphorylation triggers proteolysis, or that the target degrades
over the course of the incubation. However, it is unlikely that proteolysis or degradation
of target is occurring because no signal is ever seen in any lane at a lower molecular
weight than the major band at 45 kiloDaltons. It is unlikely that phosphatase activity is
responsible for the loss of signal because sodium fluoride is present in the reactions at
concentrations known to inhibit many phosphatases.
It was concluded from these results that reactions carried out to generate samples for
mass spectrometry, immunoprecipitation, and 2D-PAGE should be incubated for no more
than 30 minutes and that they should be frozen as soon as possible after incubation to
ensure minimal loss of signal.

3.10

Acidic conditions alter the reaction rate or equilibrium.

During the course of experimentation it was observed that when a large amount of
unlabeled ATP was added to samples, a simple direct competition effect leading to a
concomitant loss of signal was not observed. In fact, depending upon the concentrations
of ATP used, a counterintuitive signal enhancement was observed in some samples. In
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order to investigate this effect, a series of reactions titrating a fixed concentration of γ32

P-ATP with unlabeled ATP was carried out.
Reaction samples were constructed to contain approximately 6µM target protein from

DEAE purified fractions, 830 nM Doc, 25 mM sodium fluoride, 1 mM GDP, 0.1 mM
BME, 32 nM γ-32P-ATP, and either no additional unlabeled ATP or 0.01, 0.03, 0.1, 0.3,
1, 3, 10, or 30 mM of unlabeled ATP. Reactions were incubated for 45 minutes at 30°C
and then quenched by freezing at -20°C. Samples were separated by SDS-PAGE and then
autoradiographed:
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Figure 3.11: Addition of unlabeled ATP to reactions suppresses signal as expected up to 1 mM
concentration, but at higher concentrations enhances signal. Samples were made to contain 6 µM target
protein from DEAE purified fractions, 830 nM Doc, 25 mM sodium fluoride, 1 mM GDP, 0.1 mM BME,
and 32 nM γ-32P-ATP. Unlabeled ATP was omitted in the first lane and then titrated up through 0.01, 0.03,
0.1, 0.3, 1, 3, 10, and 30 mM. Maxima of activity are observed when no unlabeled ATP is added and at 30
mM while a minimum of activity is observed at 1 mM unlabeled ATP. Reactions were incubated 45
minutes.
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The resulting autoradiograph shows maxima of activity when no unlabeled ATP is
added and when 30 mM (the highest concentration tested) is added. A minimum is
observed at 1 mM unlabeled ATP. This biphasic behavior suggests that at least two
different effects are competing here. It is likely that the decreasing activity from 0.01 mM
unlabeled ATP through 1 mM unlabeled ATP is due to the expected direct competition
effect in which unlabeled ATP displaces γ-32P-ATP in the reaction. However, this does
not explain the enhanced activity at higher concentrations. It is likely that the ATP at
higher concentrations is acting as a hydrogen ion buffer, acidifying the solution. It is also
possible that ATP is acting as a general chelator and precipitator of divalent or polyvalent
metal cations.
Based on the results of this experiment, tests were conducted to determine the pH of
the ATP solution used. Its pH measured below the range of the test paper used, which
was rated to measure pH as low as 5.0. The addition of 1.5 equivalents of sodium
hydroxide was required to bring the solution’s pH up to 6.5, so its starting pH may have
been quite acidic.

3.11

Doc treatment of 2D-PAGE samples reveals that the target has an apparent
molecular weight of 41.6 kDa and an apparent isoelectric point of 4.95.

Once adequate reaction conditions had been established to generate samples with
reasonably high activity, efforts to identify the target were begun in earnest. 2D-PAGE
analysis was chosen as the next step because of its ability to separate complicated
solutions of protein with high resolving power for both molecular weight and isoelectric
point (pI) determination. It was expected that the actual chemical species of target
modified might vary from the major fraction of that protein by primary sequence length,
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covalent modification, or other structural differences. It was further expected that while
the phosphorylated product of the toxin’s activity may not shift considerably in molecular
weight, a small but non-negligible shift in isoelectric point should be observable
(Halligan, 2009).
Samples of modified and unmodified target were generated by creating two reactions:
one with Doc present and the other omitting Doc entirely. A crude BR6545 lysate was
dialyzed 16 hours against two changes of 20 mM phosphate buffer with 100 ng/mL
PMSF and 100 mM sodium chloride. 5 µL of this lysate was used as a target source in 10
µL reactions with final concentrations of 1 mM GDP, 0.1 mM BME, 50 mM sodium
fluoride, and 0.1 mM ATP plus 32 nM γ-32P-ATP. Doc was either left out of the reaction
or present at 8.3 µM. Samples were incubated 20 minutes at 30°C
2D-PAGE gels were prepared using a BioRad Protean II xi cell apparatus. Isoelectric
focusing (IEF) tube gels were poured according to the manufacturer’s directions using
BioRad Biolyte 4/6 ampholyte carriers. Samples were denatured in 9.2M urea, loaded on
top of the tube gels, and the separated at 200 VDC for 2 hours, then 500 VDC for 2
hours, and finally 800 VDC overnight. 9% SDS-PAGE gels were prepared and the IEF
tube gels were extracted from the tubes and laid over the top of the SDS-PAGE and
secured with molten agarose. Samples were separated at a constant current of 35 mA per
gel for 8 hours and stopped when the dye front reached the bottom of the gels. Gels were
stained with SimplyBlue SafeStain and compared (Figures 3.12-3.16 below).
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Figure 3.12: 2D-PAGE resolves a new species of an unidentified protein near EF-Tu after treatment
of lysate with Doc. Treatment with Doc generates a new spot with a concomitant decrease in the density of
a neighboring spot. The small leftward shift towards the acidic agrees with a single phosphorylation event,
and the decrease in the neighboring spot's density to create a couplet suggests that the new spot is a product
of phosphorylation of the original spot (circled in red). Here the image is presented both magnified and
unmagnified to highlight the spot shift.
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Figure 3.13: Autoradiography performed on the 2D-PAGE reveals that the new species observed
after treatment with Doc is the only significant radiation source in the sample. The gel and its
autoradiograph were carefully aligned and compared by using witness marks drawn on their margins (not
shown). The red circle was aligned to the same region of the autoradiograph and 2D-PAGE gel and shows
that the autoradiographic signal appears to emanate from the site of the new spot generated by treatment
with Doc.
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Figure 3.14: Software-facilitated gel matching reveals the location of the major band of EF-Tu and
permits the assignment of molecular weights and isoelectric points along gel axes. The reference gel is
presented here to the left of the experimental gel. Markers used on the 2D-PAGE and gel matching in the
computer program Flicker (Lemkin, Thornwall & Evans, 2003) were used to assign molecular weights to
the gel and were found to be in good agreement. Gel matching was then used to assign isoelectric points to
the gel. The major spot of EF-Tu was used as a convenient landmark (Bloch, Phillips & Neidhardt, 1980)
and lines were drawn to facilitate alignment, centered on the EF-Tu major spot. Marked spots on the
reference gel were used to create the final alignment. The reference gel used was retrieved from SWISS2DPAGE (Hoogland et al., 2004; Tonella et al., 1998).
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Figure 3.15: Analysis of the relative mobility of spots on the 2D-PAGE gel reveals that the modified
spot's molecular weight is approximately 41.6 kiloDaltons and that its isoelectric point is
approximately 4.92 in contrast to an isoelectric point of 4.95 for its unmodified state. Gel markers
were aligned according to molecular weight markers run on the 2D-PAGE and matching against the
reference gel, as described above. Relative mobilities were calculated by measuring the number of pixels
from a fixed reference point. For molecular weight, the loading line on the gel's second dimension (SDSPAGE) was set as zero and molecular weights were converted to log scale. For isoelectric point, 5.0 was set
as zero and mobilities were measured in both positive and negative domains using a linear scale. Data were
plotted, curves were fitted, and equations were generated using Microsoft Excel 2003. Molecular weights
and isoelectric points were then interpolated or extrapolated using the equations for the fitted curves.
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Figure 3.16: Doc-dependent phosphorylation of target results in a new spot on 2D-PAGE, with
concomitant reduction in density of a neighboring band. Measurement of the apparent MW and pI of
bands on the gel reveal that the band that is most likely modified has an approximate molecular weight of
42 kDa and pI of 4.95, whereas full-length EF-Tu identified by matching the gel against a database has an
approximate apparent molecular weight of 47 kDa and pI of 5.32. Doc-dependent phosphorylation labels a
single spot at an apparent molecular weight of 42 kDa and pI of 4.92. Both the imperceptible change in
molecular weight and 0.03 pH unit shift in pI towards the acidic agree with the transfer of a single
phosphate from γ-32P-ATP.
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It appears that Doc modifies a single target protein by transferring a single phosphate
group from γ-32P-ATP, as evidenced by the 0.03 pH unit shift towards the acidic with a
concomitant loss of density of the gel spot that is presumably being modified (Halligan,
2009). Furthermore, the target is a relatively minor gel spot on 2D-PAGE when
compared to full-length EF-Tu, which is one of the most highly expressed proteins in
many bacterial cells (Furano, 1975). This result raises some important questions about the
functional significance of various species of EF-Tu. For example, what specific
indispensable roles does this lower molecular weight and more acidic species play in
vivo, or, stated differently, how can its toxic effect be explained in the presence of excess
unmodified full-length EF-Tu?
The molecular weight of 42 kDa and pI of 4.95 exhibited by the unmodified gel spot
can potentially be explained by analyzing the effect of cleaving varying amounts of the
N-terminal sequence of EF-Tu. Its N-terminus contains a highly basic region which
coincidentally has also been proposed as the binding site for the monoclonal antibody
used in these studies. It should be pointed out here that EF-Tu has at least two epitopes
bound by the monoclonal antibody used in Sections 3.13 and 3.14 below. The literature
available for the antibody suggests that it binds not only to the N-terminal SKEKFE
epitope but also to other epitopes containing a GAARAFDQID decapeptide or HTKFE
pentapeptide sequence at positions 41-50 or 301-305, respectively, in EF-Tu's sequence
(Baensch, Frank & Köhl, 1998). In short, with one epitope present at the very beginning
of the N-terminal end and another occurring near the C-terminus, loss of either end of the
protein should not necessarily abolish antibody binding.
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Furthermore, several reference 2D-PAGE gels available show that EF-Tu exists in
multiple distinct species with different molecular weights and isoelectric points. The
SWISS-2DPAGE database shows that species' measured molecular weights range from
51.2 to 25.1 kDa and that their isoelectric points range from 5.07 to 5.69 with thirteen
possible distinct species observed and as many as seven seen on a single 2D-PAGE
(Hoogland et al., 2004).

3.12

LC-MS/MS of Doc-labeled SDS-PAGE bands reveals that Elongation FactorTu contributes the strongest MS signal.

2D-PAGE results were suggestive that the target of Doc could be EF-Tu. Since good
control of reaction outcomes was now well in hand, it was decided that a direct approach
to target identification should be attempted using LC-MS/MS analysis. The
overwhelming advantages of peptide mass fingerprinting mass spectrometry are its
extraordinary sensitivity and ability to identify phosphoryl groups and other posttranslational modifications under the right conditions (Perkins et al., 1999; Kinter &
Sherman, 2000, pp.280–290).
Samples were prepared in duplicate with γ-32P-ATP used in one half and unlabeled
ATP used in the other. This was done to allow the radiolabeled samples to provide proof
of modification of the target while allowing the modified but non-radiolabeled samples to
be sent for LC-MS/MS analysis. All reactions contained 0.5 µM of DEAE-purified target,
0.1 µM of His-tagged Doc, 1 mM GDP, 100 µM BME, 5 mM NaF, 3.5 mM MgCl2, and
30 mM EDTA. The radiolabeled sample included 32 nM γ-32P-ATP. The nonradiolabeled sample included 16 µM ATP. Samples were incubated 20 minutes at 30°C,
denatured 10 minutes at 95°C in 1x denaturing buffer, and then loaded directly onto a
75

12% NuPAGE SDS-PAGE gel and electrophoresed at 150 VDC for 45 minutes. The gel
was stained with coomassie and cut in half. The radiolabeled half was dried and placed
on film to generate an autoradiograph (Figure 3.17). The unlabeled half was stored at 4°C
overnight. The autoradiograph was developed to confirm the presence of modified target
and then the coomassie-stained band of the correct molecular weight was excised from
the non-radiolabeled lanes and sent to UAB for LC-MS/MS analysis (Figures 3.18-3.21).
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Figure 3.17: SDS-PAGE and autoradiographic analysis of samples prepared for LC-MS/MS studies
shows that the reaction conditions used yielded modified target. Samples for LC-MS/MS were prepared
in standard assay conditions, incubated, and then separated by SDS-PAGE. The experiment was performed
in duplicate, with γ-32P-ATP applied to the reactions on one half of the gel and non-radiolabeled ATP
applied to the other half in order to facilitate both analysis by autoradiography and allow the unlabeled
samples to be sent by overnight carrier to UAB's TMPL. Lane 1 contains 5 mL of prestained PageRuler+
molecular weight markers, lane 2 and 3 contain DEAE-purified fractions of E. coli lysate. Lane 3 was
treated with His-tagged Doc and lane 2 did not contain a source of Doc. Lane 4 contains bovine serum
albumin for use as an LC-MS/MS control, and lane 5 contains only IMAC-purified His-tagged Doc. A
strong signal is apparent at approximately 45 kDa on the autoradiograph in lane 3 only. The dense
coomassie-stained bands visible at approximately 45 kDa in lanes 2 and 3 on the SDS-PAGE were excised
from the non-radiolabeled gel and sent to UAB for LC-MS/MS analysis along with the major band for
BSA, which is visible in lane 4 at approximately 60 kDa.
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Figure 3.18: Sample of LC-MS/MS data yielding AGENVGVLLR sequence matching residues 270279 of E. coli EF-Tu. The liquid chromatogram highlights the major peak which has a retention time of
26.603 minutes on the LC stage's C18 reverse phase column (top). The peak was sampled into the ion spray
time-of-flight MS/MS instrument's first stage to generate the precursor ion spectrum showing a major peak
at 514.2998 m/z and three sequentially smaller peaks at approximately 0.5, 1.0, and 1.5 m/z (middle). The
precursor ion was fragmented and further analyzed in the second MS stage to characterize the m/z values
for the peptide fragment ions (bottom).
.
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Figure 3.19: Fragmentation mass spectrometry of the major precursor ion at 514.2998 m/z reveals
the sequence AGENVGVLLR, matching residues 270-279 of E. coli EF-Tu. The peptide fragment mass
spectrum (top) yielded strong signals for nineteen of the eighty-four predicted fragment ions expected for
the sequence AGENVGVLLR (bottom). All of the predicted ions are shown in the table. Bolded red m/z
values are those of the nineteen fragments with the strongest signals identified by the LC-MS/MS
instrument. These data are presented as representative of multiple LC-MS/MS hits leading to the
identification of EF-Tu in the samples.
.
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Figure 3.20: Summary of all proteins in the E. coli sequence database matched by the MASCOT
software during LC-MS/MS analysis of samples. MOWSE scores represent a log scale measure of the
probability of any given match against the database occurring by chance. MOWSE scores are calculated as
equal to -10log10(P) where P is the probability of matching by chance (Perkins et al., 1999). These scores
are intended to make data interpretation more intuitive because, as can be seen in this table, probabilities of
chance matches for peptide mass fingerprinting with LC-MS/MS can be very low. A MOWSE cutoff of 80
is used to establish significance in this analysis. These data indicate that the major component of both
samples prepared for LC-MS/MS analysis is EF-Tu. Doc is present in both samples, suggesting that the
Doc-free samples may have been contaminated or the Doc-treated sample may have been run twice through
the instrument.
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Matched peptides shown in Bold Red
gi|11514297
gi|4699821

1 SKEKFERTKP HVNVGTIGHV DHGKTTLTAA ITTVLAKTYG GAARAFDQID
1 SKEKFERTKP HVNVGTIGHV DHGKTTLTAA ITTVLAKTYG GAARAFDQID

gi|11514297
gi|4699821

51 NAPEEKARGI TINTSHVEYD TPTRHYAHVD CPGHADYVKN MITGAAQMDG
51 NAPEEKARGI TINTSHVEYD TPTRHYAHVD CPGHADYVKN MITGAAQMDG

gi|11514297 101 AILVVAATDG PMPQTREHIL LGRQVGVPYI IVFLNKCDMV DDEELLELVE
gi|4699821 101 AILVVAATDG PMPQTREHIL LGRQVGVPYI IVFLNKCDMV DDEELLELVE
gi|11514297 151 MEVRELLSQY DFPGDDTPIV RGSALKALEG DAEWEAKILE LAGFLDSYIP
gi|4699821 151 MEVRELLSQY DFPGDDTPIV RGSALKALEG DAEWEAKILE LAGFLDSYIP
gi|11514297 201 EPERAIDKPF LLPIEDVFSI SGRGTVVTGR VERGIIKVGE EVEIVGIKET
gi|4699821 201 EPERAIDKPF LLPIEDVFSI SGRGTVVTGR VERGIIKVGE EVEIVGIKET
gi|11514297 251 QKSTCTGVEM FRKLLDEGRA GENVGVLLRG IKREEIERGQ VLAKPGTIKP
gi|4699821 251 QKSTCTGVEM FRKLLDEGRA GENVGVLLRG IKREEIERGQ VLAKPGTIKP
gi|11514297 301 HTKFESEVYI LSKDEGGRHT PFFKGYRPQF YFRTTDVTGT IELPEGVEMV
gi|4699821 301 HTKFESEVYI LSKDEGGRHT PFFKGYRPQF YFRTTDVTGT IELPEGVEMV
gi|11514297 351 MPGDNIKMVV TLIHPIAMDD GLRFAIREGG RTVGAGVVAK VLG
gi|4699821 351 MPGDNIKMVV TLIHPIAMDD GLRFAIREGG RTVGAGVVAK VLS

Figure 3.21: Alignment of the two identified EF-Tu sequences reveals minimal difference. As can be
seen in Figure 3.20 above, two different accession numbers are given for EF-Tu. Here the two different
sequences are aligned, showing the observed peptides in bolded red. The two sequences are for the EF-Tu
protein product of the two different genes tufA and tufB, which vary only at the final C-terminal residue,
having either a glycine or a serine. Here EF-Tu 1 (encoded by the tufA gene and ending with a C-terminal
glycine) is unambiguously identified, though the absence of a signal for EF-Tu 2's C-terminal VLS peptide
is not proof of absence of EF-Tu 2 in our samples.
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The clearest interpretation of these data is that EF-Tu is the major component of the
radiolabeled SDS-PAGE bands located at approximately 45 kDa molecular weight. These
data do not rule-out other proteins, though the strength of the EF-Tu signal is suggestive.
It is still possible that the target is some other protein identified by the LC-MS/MS. Of
these, two in particular stand out: YchF, a GTP-dependent nucleic acid binding protein
with 2D-PAGE-mapped molecular weights of 42.6 and 42.2 kDa and pIs of 5.02 and 5.03
(Tonella et al., 2001; Yan et al., 2002), and peptide chain release factor 2 (RF-2) with a
theoretical molecular weight of 41.3 kDa and pI of 4.69 (Han & Lee, 2006). In light of
these results, an orthogonal approach was sought to test whether or not EF-Tu is the
target of Doc and rule-out YchF and RF-2, if possible.

3.13

Doc labels a target that is immunoprecipitated by an anti-EF-Tu monoclonal
antibody.

A monoclonal antibody that binds EF-Tu was procured in order to perform
immunoprecipitation experiments (Weber, Lottspeich & Köhl, 1995). The monoclonal
antibody binds EF-Tu's N-terminal SKEKFE and two other epitopes including one near
the C-terminus. Only the FE is indispensable so long as one or more lysine residues are
available unconstrained and in close proximity. All other residues can be substituted with
other AAs, though some anti-conservative substitutions abolish binding (Baensch, Frank
& Köhl, 1998). A brief analysis of the protein sequences for YchF and RF-2 available via
the NCBI Protein database portal reveals that neither contains a suitable epitope for
binding of the monoclonal antibody (Pruitt et al., 2012).
Samples were generated using crude lysate or partially DEAE-purified fractions as the
source of target. Reaction conditions were 14 nM His-tagged Doc, 1 mM GDP, 0.3 mM
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EDTA, 1 mM BME, and 32 nM γ-32P-ATP incubated 30 minutes at 30°C. Samples were
bound to antibody-bound resin for one hour at room temperature. Antibody-bound
sample was washed five times with RIPA and all washes were saved, TCA precipitated,
and run on the gel. After washing, samples were eluted directly in 1x denaturing buffer
and run on a 12% NuPAGE SDS-PAGE gel. The gel was stained, photographed, and
autoradiographed, yielding the following results:
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Figure 3.22: An anti-EF-Tu monoclonal antibody immunoprecipitates the radiolabeled target.
Partially DEAE-purified target was used as the source of target. Lane 1 is a molecular weight marker, lane
2 is the total loaded sample equivalent to that loaded onto the antibody-bound resin, lane 3 is the sum of the
RIPA washes, lane 4 is monoclonal antibody equivalent to that bound to the resin but with no other protein
loaded, lane 5 is monoclonal antibody and immunopreciptate, and lane 6 is an irrelevant polyclonal
antibody loaded to demonstrate an absence of nonspecific binding. A saturating amount of the monoclonal
antibody immunopreciptates approximately half of the labeled target in the reaction. Numerous trials
confirmed that increasing the antibody present does not increase the fraction of labeled target
immunoprecipitated. Partially DEAE-purified target gave superior results to a crude lysate (not shown).
The dense band visible in lane 3 at approximately 65 kDa is BSA, added to the immunoprecipitation
reaction to prevent nonspecific binding.
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The gel and autoradiograph show two interesting findings. First, about half of the
target is immunoprecipitated and about half is lost in the wash. Second, there appears to
be a significant amount of silver stain density lost on the SDS-PAGE when one compares
the sum of the wash and immunoprecipitate (lanes 10 and 12) versus the loaded sample
(lane 9), though the autoradiograph shows that not nearly so much of the
autoradiographic signal is lost. Immunoprecipitation was repeated a number of different
ways, and no matter how much antibody or how little target was used, only about half of
the target was ever observed to be immunoprecipitated. The most likely interpretation of
this result is that there are two or more different species of target present, one with an
intact, exposed epitope and another with a sequestered or absent epitope.
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CHAPTER 4

CONCLUSIONS

4.1 Summary of Results and Remaining Questions
At the beginning of this project it was known only that Doc appears to inhibit
protein translation (Hazan et al., 2001). More recently the Woychik lab had claimed that
Doc's inhibition of protein synthesis results from it directly binding the 30s ribosomal
subunit (Liu et al., 2008). However, this claim was made primarily due to the indirect
observation that a mutant strain of E. coli is resistant to both Doc and hygromycin B, an
antibiotic that prevents movement of tRNA from the ribosomal A-site to the P-site
(Brodersen et al., 2000). Shortly thereafter it was shown that Doc has significant
homology to Fic, an AMPylating enzyme of the Rho family of GTPases, suggesting that
Doc itself might be an enzyme (Kinch et al., 2009). This was the impetus for two
different projects in the Magnuson lab-- Stephanie Cale's project in which she determined
that Doc is an enzyme that phosphorylates a protein target (Cale, 2014), and this project
which has endeavored to identify the particular protein that Doc targets for
phosphorylation.
In this present work, the author has provided direct evidence in support of the several
claims summarized below:
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1. Active Doc has been expressed and purified to the exclusion of Phd (Sections 3.13.2)
2. The protein target of Doc is present in E. coli crude lysates, fractions of lysates
subjected to anion exchange, and commercial S30 extracts (Sections 3.2-3.4)
3. The target of Doc coelutes from anion exchange in the same fractions and at the
same molecular weight as EF-Tu, as determined by Western blotting (Section 3.5)
4. Doc targets a single protein species of approximately 41.6 kDa molecular weight
and pI 4.95, causing an apparent isoelectric point shift of 0.03 points towards the
acidic and no apparent shift in molecular weight, as determined by 2D-PAGE
(Section 3.11)
5. EF-Tu is the major component of the SDS-PAGE band phosphorylated by Doc, as
determined by LC-MS/MS (Section 3.12)
6. The target phosphorylated by Doc is immunoprecipitated by an anti-EF-Tu
monoclonal antibody after Doc-dependent phosphorylation is performed (Section
3.13)
The concluding claim of this thesis is that some species of EF-Tu is the major target of
Doc, though it appears that the major fraction of EF-Tu present in vivo is not the target.
In fact, the major fraction of EF-Tu identified by gel matching in Figure 3.14 above
shows no radiolabel signal whatsoever on autoradiography whereas the species exhibiting
strong signal is clearly present at much lower concentration. The author has no doubt that
the modified spot is, in fact, EF-Tu because he has obtained orthogonal identifying
results by immunoprecipitation and mass spectrometry. Additionally, shortly before the
completion of this project, two groups working independently made new claims, well
supported by their data, regarding the molecular mechanism of Doc toxicity. In
December 2013 the Garcia-Pino group claimed that Doc’s toxicity is due to specific
phosphorylation of EF-Tu (Castro-Roa et al., 2013). In January of 2014 the Woychik
group made an identical claim publishing similar experimental results (Cruz et al., 2014)
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Both groups identified the conserved threonine at position 382 on EF-Tu as the solitary
site of Doc-dependent phosphorylation.
The question that then remains is what is the biological significance of this minor
species of EF-Tu if a toxin acting against it can kill the cell despite the presence of a
much larger quantity of the unmodified major species? Structural and molecular studies
of the role of EF-Tu in translation have focused on the full-length molecule and have not
suggested the existence of any significant minor species (Moazed, Robertson & Noller,
1988; Ehrenberg et al., 1990; Nissen et al., 1995). However, it does appear that
unsequestered Doc leads rapidly to ribosome stalling and translation arrest (Liu et al.,
2008). It is likely that one of two mechanisms accounts for toxicity: 1) the
phosphorylated minor species of EF-Tu enters into and inhibits some known pathway
related to translation, or 2) phosphorylation of EF-Tu results in the inhibition of some
unknown activity for which the minor species was not previously known to be
responsible. A simple loss of the activities that the major fraction of EF-Tu is responsible
for is highly unlikely given that the major fraction is neither depleted nor labeled by the
action of Doc. However, it is possible that the minor fraction of lower molecular weight,
more acidic EF-Tu found to be modified in the described 2D-PAGE experiments has a
critical specific activity for which its larger, less acidic parent species cannot compensate.
It is also possible that rather than a simple loss of activity a direct interference has been
created such that EF-Tu modified by Doc-dependent phosphorylation inhibits some
necessary pathway. This explanation is particularly appealing because it could resolve the
problem intrinsic to a highly specific toxin that has selected a target present at high
concentration in the cell: how does a small amount of toxin modify sufficient target to
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achieve a significant interruption of the target's normal functions? Future experiments
should be aimed at unraveling this mystery to determine whether or not Doc-dependent
phosphorylation has hinted at one or more unknown roles for the observed minor species
of EF-Tu in the maintenance and operation of the translational machinery.
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